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GENERAL INTRODUCTION 
Pituitary extracts were shown as early as 1931 to be capable of 
stimulating growth (1). The slow development of adequate technologies 
for protein purification and amino acid sequencing techniques, however, 
delayed the identification of the amino acid sequence of ovine and 
bovine growth hormone (GH) until 1972 (2-3). However, in the mid-1960s, 
radioimmunoassays were developed to evaluate endocrine concentrations 
(4-5), which started a rapid acceleration in endocrinology research. 
Using these developments, several studies were conducted using 
purified GH from pituitary glands to stimulate growth in cattle and 
sheep (6-10). The anabolic potentials of these GH administrations were 
variable, and were probably due to contaminants in the preparations and 
the limited quantities of GH actually available. Although the 
purification techniques today have eliminated many of the previous 
problems incurred with earlier GH preparations, pituitaries still have 
to be obtained from the species which will eventually receive the GH 
preparation. 
The development of recombinant deoxyribonucleic acid (DNA) 
techniques has allowed for the rapid production of large quantities of 
proteins that have biological activities similar to the naturally 
produced proteins, including GH (11-16). Because GH produced by 
recombinant DNA techniques is now available for research, and possibly 
for administration to livestock in the near future, the ways in which GH 
has to be effectively administered to animals to enhance growth has 
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become increasingly inportant. One concern with the administration of 
GH has been its susceptibility to enzymatic degradation if administered 
as a slow release implant. Furthermorer native GH, or that produced by 
recombinant DNA techniques, has the possibility of inducing antigenic 
effects with longterm administration. An approach to avoid these side 
effects of GH during long-^term administration has been to introduce GH 
genes into the genome in order to increase the GH concentration in the 
plasma of growing animals (17*18). GH and growth were stimulated in 
some transgenic mice in this way, but this was very expensive and 
tedious. In addition, the technique worked with very low efficiency, 
only a small fraction of treated animals responding, and in many, 
deleterious mutations were produced. 
An alternative method of providing effective growth stimulation in 
animals may be the use of GH-releasing factor (GHRF). GHRF is a small 
peptide of 44 amino acids, which releases GH from the pituitary. Being 
a smaller protein than Œ, GHRF would have less chance of stimulating an 
antigenic response in animals. GHRF has the additional benefit of 
requiring lower doses than GH in order to cause an increase in plasma GH 
concentrations. Because of the recent isolation and sequencing of GHRF 
(19-20), very little is known about GHRF as a potential anabolic agent 
in domestic animals. Since its isolation, GHRF has been shown to 
increase growth rates in humans and rats (21-22), but only two studies 
have been conducted in ruminants. In sheep, GHRF administration did not 
alter growth rate (23). In calves, GHRF administered as a continuous 
infusion for 20 days increased nitrogen retention between days 9-13 
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(24). Based on these contradictory results in ruminants, the 
relationships between GHRF, GH and growth in ruminants need to be 
defined more accurately under different gAysiological conditions in 
order that the application of GHRF to enhance growth in farm animals may 
be effective. 
The purpose of these works was to increase our understanding of GH 
secretion in growing ruminants. In a series of experiments, the 
influences of sex, castration, and aging on GH profiles, GH secretion 
and clearance rates, GH half-life, and GH response to GHRF were examined 
as well as the corresponding concentrations of somatomedin, thyroid 
hormones, insulin, sex steroids, and body composition. In addition, the 
GH responses to Œ1RF and somatostatin administration were studied in 
cattle. GHRF was tested in she^ and cattle for its ability to 
stimulate a GH response and an anabolic response. The overall objective 
of these studies was to provide additional information about endogenous 
GH secretion so that it could be manipulated by GHRF to increase weight 
gain in ruminants. 
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REVIEW OF THE LITERATURE 
Background 
From the earliest times, the existence of a substance controlling 
growth in animals and humans has been postulated. The Greek physician 
and scholar Galen (129-199 AD) put forth the view that blood ebbed to 
and fro in the arteries carrying "vital spirit" to various organs of the 
body. "Animal spirit" was believed to be formed from "vital spirit" in 
the brain, with the wasted products of this reaction flowing down the 
base of the brain and pituitary stalk to the pituitary. The pituitary 
or "phlegmatic glandule" conducted the waste products by ducts to the 
nasopharynx where they appeared as nasal mucous or pituita. In the 17th 
century, Conrad Victor Schneider and Richard Lower argued that 
anatomical fluids could not pass from the brain to the nose and that the 
foramina in the bone were used for olfactory nerve transmission. Thus, 
the fluids passed down the pituitary stalk to the gland which 
"distilled" them back into the blood (25). 
The central role of the pituitary in growth was established when it 
was shown that removal of the pituitary gland, or hypophysectomy, 
resulted in dwarfism (26-29). Furthermore, when a growth factor 
isolated from the pituitary was administered to hypophysectcmized rats 
which had limited growth, growth was restored (26-30). This growth 
factor, or growth hormone (GH), was believed to act directly on tissues 
to stimulate growth. However, a GH-dependent factor was found to be 
present in serum that stimulated iji vitro incorporation of sulfate into 
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cartilage (31). Based on these results, it was postulated that GH 
stimulated skeletal growth indirectly through generation of a sulfation 
factor. Plasma extracts containing the sulfation factor were 
subsequently shown to have a variety of effects on cartilage and to have 
insulin-like activity in other tissues. Some of these insulin-like 
properties included the inhibition of lipolysis and the promotion of 
glucose oxidation in adipose tissue, enhancement of protein synthesis 
and glucose uptake in muscle, and stimulation of sulfate uptake, amino 
acid transport and synthesis of ribonucleic acid (RNA), deoxyribonucleic 
acid (DNA), protein and chrondroitin sulfate in cartilage (32%33). Due 
to the diverse actions of sulfation factor on many tissues of the body, 
and because it appeared to be an intermediate factor in the action of GH 
on growth, it was later called somatomedin (Sm-C). 
Stimuli responsible for regulating the secretion of GH were 
suggested in 1947. Green and Harris postulated that humoral substances, 
later termed releasing factors, were liberated from nerve tracts of the 
hypothalamus. These releasing factors were carried into the primary 
plexus of capillaries of the hypophysial-portal vessels where they were 
transported to the adenohypophysis. Within the adenohypophysis, they 
regulated hormonal release by stimulation or inhibition (34). The first 
evidence for a GH-releasing-inhibiting hormone, called somatostatin 
(SRIH), was amassed in 1968 (35) and the peptide was sequenced in 1973 
(36). With this discovery of negative regulation, a dual controlling 
system for hypothalamic GH secretion was suggested (35). However, the 
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positive regulator, GH-releasing factor (GHRF), was not isolated and 
sequenced' until 1982 (19-20). 
Initially, GH levels in the plasma were considered to be relatively 
constant. Later, it was demonstrated that the secretion of GH was 
pulsatile (37^38). SRIH and GHRF are secreted into the 
hypophysial--portal circulation (39) and, acting as dual regulators, 
influenced the pattern of GH secretion (40-45). In rats, the release of 
GHRF and SRIH generated a ultradian rhythm of GH secretion (45), which 
varied between the sexes. The male rat had a secretory pattern of high 
pulses at 3- to 4-hr intervals returning to low concentrations, whereas 
females had a high baseline of GH with smaller pulses (46). Due to the 
different growth rates of the sexes, the GH pattern of secretion was 
thought to influence the growth rate (46). Examining this postulate, 
Jansson et al. (46-48) demonstrated that administration of GH in the 
male-type pattern to hypophysectomized rats stimulated growth to a 
greater extent than the female-'type pattern of GH administration. 
In ruminants, GH is secreted with peaks occurring at randcxn. The 
episodic secretion of GH has found to be different between breeds having 
different growth rates, between various ages of ruminants, between 
sexes, and between intact and castrated ruminants (37^38, 49-<51). The 
importance of the pattern of GH secretion in ruminants has not been 
established. Moseley et al. (52) administered GH in various patterns to 
cattle, but differences in growth rates were not observed. However, it 
has been found that intact males, which have higher weight gains of less 
adipose tissue than castrates or f anales, have more GH in the plasma 
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with a higher baseline and higher anplitude of the secretory periods 
than castrated males (50). Bulls also have a greater secretion rate of 
GH without a greater metabolic clearance rate (i.e., the rate at ^ich 
the GH protein is metabolized or broken down in the body), whereas 
heifers have a greater metabolic clearance rate but no increase in the 
secretion rate of GH, resulting in lower levels of plasma GH (53). 
Therefore, it was proposed that GH secretion rates affect plasma Qi 
concentrations to a greater extent than the metabolic clearance rates 
(54). 
GH concentrations in the plasma were influenced by the nutritional 
status of cattle. When cattle were fed at high levels, Œ peaks of 
secretion were of low amplitiude and short duration, whereas, at medium 
and low planes of nutrition, GH pulses were high with multiple peaks and 
slow decay (55). These differences in GH secretion may have been caused 
by a longer half^life of GH and a lower metabolic clearance rate which 
have been observed in fasting animals (56). 
GH concentrations in the plasma have been shown to decline with age 
in animals (57-59). In cattle, the GH secretion rate per unit of body 
weight and the pituitary weight per unit of body weight diminished with 
age (60). The general decrease in Œ concentrations as the animals were 
increasing in body weight resulted in low correlations between GH levels 
and growth rate (59). 
GHRF and SRIH Regulation of GH 
The hypothalamic releasing factors, GHRF and SRIH, as mentioned 
previously, act as positive and negative regulators, respectively, of GH 
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secretion from the hypothalamus; GHRF administration has been shown to 
induce a release of plasma GH in ruminants (23, 61-64). GH was released 
in response to intravenous administration of GHRF in a dose-dependent 
manner which peaked within 5 to 15 min after injection (23, 61^64). It 
did this by increasing the rate of transcription of GH messenger RNA in 
somatotrophs (65-66). This messenger RNA was more stable when 
triiodothyronine was present. When glucocorticoids were also present, 
Œ1 messenger RNA accumulation by transcriptional and 
post-transcriptional means increased (67^68). 
GHRF has not always been found effective in producing a GH 
response, probably due to competition with other physiological events, 
such as elevated levels of SRIH or negative feedback from endogenous 
levels of GHRF, GH, or Sm-C (22). On the other hand, the response to 
GHRF may be potentiated by administering the peptide during an 
endogenous GH secretory period (45, 69). 
Although SRIH inhibited GH secretion from the pituitary, SRIH did 
not inhibit GH gene transcription and GH synthesis (22). Administration 
of SRIH in all species tested resulted in decreased concentrations of GH 
in the plasma (70-72). After SRIH administration was halted, GH levels 
rebounded above normal baseline values which created a peak of GH 
secretion (73-76). It has also been danonstrated that the magnitude of 
the GH peak following SRIH administration can be enhanced by the 
administration of GHRF during the SRIH infusion (76-78). 
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Endocrine Relationships with GH 
Apart from the effects of GHRF and SRIH, several other hormones 
influence GH during the growth process. In addition to being dependent 
on GH, the release of Sm-C by the liver seems to require adequate levels 
of insulin (32, 79), Similarly, the ability of Sm^ to stimulate growth 
at the tissue level may be dependent upon thyroid hormones (79-80). 
Thyroid hormones stimulate GH synthesis and secretion (68, 81). In 
ruminants, GH concentrations have been stimulated by estrogen 
administration (49, 82). Estrogens also stimulated weight gain. 
Although estrogens stimulated growth in ruminants, in humans, estrogens 
depressed Sm-'C concentrations (83). Elevated concentrations of SmC 
have been associated with increased growth. GH is required for 
androgens to stimulate musculature and skeletal growth (80). Androgens 
may act as estrogens stimulating these growth processes, because 
testosterone can be aromatizated to estradiol in the peripheral tissues 
(84). In other words, the ability of androgens to enhance GH secretion 
may be estrogen-mediated (84-86). Androgens inhibited binding of 
steroids from the adrenal cortex to their receptors in muscle permitting 
muscle growth (87). In addition, large doses of some adrenal cortex 
steroids have inhibited GH secretion (80). Elevated levels of adrenal 
cortex steroids inhibited the effects of insulin on muscle protein 
synthesis (88). 
Insulin action is antagonized by GH in adipose tissue. This 
results in GH acting to divert nutrients away from lipid synthesis in 
adipose to other body tissues (89-90). Insulin has been shown to 
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increase amino acid uptake, protein synthesis, and may be involved 
directly in muscle growth (80). GH itself has been shown to be 
necessary for tissue growth. Receptors for GH in adipose tissue were 
shown to allow GH to affect directly tissue in several ways by 
stimulating lipolysis, fatty acid turnover rates in farm animals (80), 
and preadipocyte conversion to adipocytes, a process which requires 
extensive reorganization of gene expression (91). In muscle tissue, Qi 
increased protein synthesis and the muscle mass by affecting the rate of 
DNA synthesis and uptake of amino acid (80, 92). ^ vitro, Gtt 
stimulated differentiation of multinucleated muscle cells from cultured 
myoblasts, suggesting that it also stimulates cell differentiation in 
muscle tissue (91). Additional suRwrt for the affects of GH on muscle 
growth comes from the positive correlation between GH and total muscle 
mass reported in steers (59, 92). GH enhanced bone growth via 
somatomedin stimulation (80). It also stimulated the differentiation of 
prechondrocytes to chondrocytes in the growth plate which undergo clonal 
expansion, a process v^ich is dependent upon Sm-C (91). However, 
experiments to show a correlation between baseline GH or GH-^stimulated 
Sm-C levels and growth rates have not always resulted in significant 
relationships (93%94). 
Exogenous Endocrine Anabolic Agents 
To understand the endocrine regulation of growth, experiments have 
been conducted administering different hormones in growing animals. 
Because many of these hormones resulted in significiant increases in 
growth rates in hypophysectomized and intact animals, it resulted in 
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commercial application of hormones as anabolic agents. Administration 
of GH to ruminants has been shown to increase nitrogen retention and, in 
some experiments, to enhance weight gains (6-10, 52, 82, 95-96). 
Animals receiving GH excreted less nitrogen in the urine, resulting in 
enhanced nitrogen retention. This demonstrated that GH has a 
postabsorptive metabolic effect on nitrogen (52, 96). 
The sex steroids have been shown to increase GH secretion and 
enhance weight gain and feed conversion in ruminants (49, 95, 97). The 
estrogens acted by decreasing urinary nitrogen excretion to enhance 
nitrogen balance (98). The baseline and spike amplitude of plasma GH 
were higher with estrogen administration in ruminants (49). Pituitary 
weight increased with estrogen treatment on an absolute weight basis and 
in relation to body weight (98). The adrenal glands of ruminants may 
have produced androgens in response to estrogens to enhance growth (98). 
Exogenous androgens, however, have not been widely used to increase 
growth of ruminants (99-101), however. Nevertheless, there was an 
additive effect of estrogen and androgens on growth (99, 101). 
Although Sm-C has been considered to be responsible for increased 
growth, few experiments administering Sm-C to animals have been 
conducted (102-106). When Sm^ was administered to rats as a continuous 
infusion, increases in epiphyseal cartilage width and in the 
DMA-synthesizing activity of rib cartilage were found to be similar to 
those caused by GH infusion. When a Sm-C, produced in bacteria from 
recombinant DMA procedures (15, 105), was administered to 
hypophysectomized rats in a variety of regimens and doses for 6 or 8 
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days, body weight gain was increased when a high dose was administered 
continuously (105). Longitudinal bone growth was also increased with 
subcutaneous injections of Sm-C. However, GH was much more effective in 
stimulating weight gain than Sm-C even at 50-fold lower doses (105). 
As mentioned before, GHRF has been shown to stimulate GH secretion 
in ruminants. GHRF administered to cattle for 5 days increased GH 
without altering the GH secretory patterns, and the GH response did not 
diminish over this period (107). When GHRF was administered to female 
rats as pulses which reproduced the male's secretion pattern of GH, 
growth increased. However, when GHRF was administered as a continuous 
infusion which reproduced the female's secretory pattern of GH 
secretion, GHRF was ineffective as a growth stimulus (21). In bull 
calves administered GHRF as a continuous infusion for 20 days, basal 
GHRF was increased and there was a rise in the number and amplitude of 
GH pulses. On days 9 to 14 of the study, GHRF increased urinary 
nitrogen, increasing nitrogen balance without affecting nitrogen intake, 
fecal nitrogen, or nitrogen digestibility (24). This type of anabolic 
response, stimulated by administration of GHRF, is similar to that 
observed with GH. In sheep, GHRF administration did not stimulate 
growth rate, feed intake or feed efficiency (23). In a novel attempt to 
enhance endogenous GHRF secretion, the human GHRF gene was incorporated 
into the mouse genome. Transgenic mice that expressed the GHRF gene 
increased their somatic growth considerably (18). 
Antibodies to SRIH have also been used to enhance growth. In one 
study, immunization of sheep with SRIH antibodies resulted in enhanced 
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GH secretion without affecting growth rate (108). In another, growth 
was enhanced 15%, but GH levels were unaltered (109-110). These sheep 
had larger carcasses, but no changes in the proportion of muscle, fat 
and bone were observed in the carcasses. 
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ABSTRACT 
The effect of growth hormone-releasing factor (GHRF) on nitrogen 
retention and weight gain was measured in eight crossbred wethers, each 
of which was given six intravenous (iv) injections of GHRF per day. 
Wethers averaging 42 kg were used in a crossover design for the 
experiment. Nitrogen balance was evaluated over 5-day periods during 
which injections of a buffer solution with or without 0.067 ug human 
pancreatic (hp) (1-40) GHRF/kg body weight was administered at 4-hr 
intervals. Sheep administered GHRF differed from controls with a 7% 
decrease in urinary nitrogen (P<0.03). Wethers treated with GHRF did 
not differ from controls in weight gain, nitrogen retention, apparent 
nitrogen digestibility, dry-matter intake, or apparent biological value. 
Blood samples were takai before and after one of the six daily 
injections. Of the 40 GHRF pulse injections sampled, the animals 
responded 36 times with increased plasma growth hormone (GH) 
concentrations. The pattern of GH response was a spike 5-10 min after 
injection, which returned to baseline within 20 min. Plasma urea 
nitrogen, somatomedin-C, insulin, triiodothyronine, thyroxine, and 
Cortisol concentrations did not differ between treatments. These 
results suggest that pulsatile injections of GHRF over long experimental 
periods may induce an anabolic response in sheep. 
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INTRODUCTION 
Availability of growth hormone-releasing factor (GHRF) offers an 
alternative method to study growth hormone (GH) physiology because 
exogenous GHRF can be used to change the endogenous GH secretion 
pattern. Clark and Robinson (1) mimicked GH secretory patterns of male 
rats in female rats by pulse injections of GHRF every 3 hr for 12 days. 
The superimposed male pattern promoted an increase of 30% in body weight 
gain over control female rats. Administration of monoclonal antibodies 
against rat hypothalamic GHRF to male rats abolished GH surges and 
decreased growth rate (2-3). Simultaneous administration of GHRF 
antibodies and antisomatostatin serum to male rats did not alter the 
inhibitory effect of GHRF antibodies on Œ release, suggesting that 
hypothalamic GHRF release was required for pulsatile GH secretion (2). 
Although cattle and sheep secrete GH episodically, the pattern is not as 
well defined as in rats (4^9). The objectives of the present 
experiments were to determine if pulsatile injection of GHRF could 
consistently release GH over time and to determine if GHRF injections 
affected nitrogen metabolism in growing sheep. 
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MATERIALS AND METHODS 
Experiments were conducted to establish the dose of GHRF required 
to release endogenous GH in sheep within the physiological range (Exp. 
1), to determine if sheep respond to multiple injections of GHRF with a 
persistent increase in GH (Exp. 2), and to evaluate the anabolic 
response to repeated injections of GHRF in growing sheep (Exp. 3). 
For all experiments, crossbred wethers were adapted to metabolism 
crates and housed in an environmentally controlled room at 18"C with 
12-hr photoperiods. The she^ were fed the diet described in Table 1 at 
12 hr intervals at a level to allow for orts. Animals were weighed, and 
an indwelling catheter (vinyl, 1.02 mm i.d.. Beeton-Dickson) was 
inserted in a jugular vein, 1 day before experimentation. The catheters 
were filled with sterile saline containing 100 U heparin/ml between 
injections and sterile saline with 20 U heparin/tnl when blood sanples 
were being taken. Animals received injections of human pancreatic (hp) 
(1-40)-OH GHRF (10). The GHRF was dissolved in 0.1% acetic acid (1 
ug/ul) and then diluted with a sterile buffer solution. The buffer was 
physiological saline (0.818% NaCl) containing 0.01 M NaH2P0^*H20, pH 
7.0; 0.01% ascorbic acid and 0.13 ml sheep plasma/ml. Solutions for 
injection were prepared on alternate days and stored at 4'*C until used. 
Blood samples were treated with heparin (40 U/10 ml) and stored at 
-15*C until analyzed. All plasma samples were assayed for GH 
(11). The GH assay had intra-* and inter-assay coefficients of variation 
of 3% and 17%, respectively. Insulin concentrations were measured in 
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Exp. 2 and 3 (12). Intra* and inter-assay coefficients of variation of 
the insulin assays were 2% and 3%, respectively. Plasma samples from 
individual animals for each day in Exp. 3 were pooled and assayed for 
somatanedin-C (SmC), triiodott^ronine (Diagnostics Product Corp., Los 
Angeles, CA), thyroxine (Diagnostics Product Corp., Los Angeles, CA), 
Cortisol (Diagnostics Product Corp., Los Angeles, CA), and plasma urea 
nitrogen (Micro-urea, Technicon N-10a, Autoanalyzer). All 
radioimmunoassay kits were tested for parallelism by using ovine plasma 
at a minimum of three volumes. All the samples were assayed within one 
assay for each hormone. The intraassay coefficients of variation ranged 
from 1.4% to 1.8%. 
Sm-C concentrations were determined by using a double antibody 
disequilibrium radioimmunoassay procedure purchased front Imnnuno Nuclear 
Corp. (Stillwater, MN). The procedure was modified by using, 
acidification to remove the binding protein as previously described for 
ovine plasma (13), rather than using the octadecasilyl (CBS)-silica 
extraction column included in the kit. Plasma sairples were acidified by 
adding an equal volume of pH 3.2, 0.1 M glycine-HCl and incubating at 37® 
C for 24 hr. After incubation, samples were neutralized with 0.1 M 
NaOH. Purified Sm-C isolated from human serum served as standard. 
Samples of extracted plasma were incubated with rabbit anti^serum 
against the synthetic 53-70 amino acid fragment of Sm-C for 2 hr at 4*C, 
followed by a second incubation with 53-70 fragment for 20 hr at 4' 
C. Normal rabbit serum, pre-precipitated with goat anti-rabbit serum 
and polyethylene glycol diluted in a bovine serum-albumin borate buffer 
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with merthiolate, was then added in a single step, and after 2 hr at 4^ 
C, the tubes were centrifuged, and the supernatant was decanted. 
Table 1. Composition of diet (dry-matter basis) 
Percent 
Corn, cracked 44.7 
Cobs, ground 35.2 
Molasses, cane 11.3 
Soybean meal, solvent-^extracted 7.2 
Dicalcium E*iosphate 0.5 
Salt, iodized 0.5 
Limestone 0.3 
Trace mineral mixture 0.1 
Sulfur, elanental 0.1 
Vitamin A (5.2 million lUAg) 0.01 
Vitamin D 150 lUAg 
The results were expressed as nMol/liter, which can be converted to 
ng/ml by multiplying by 7.7. The six standards provided in the kit 
ranged frran 2.19 to 70.0 nMol/liter. Two quality-control plasma samples 
were included in each assay with mean concentrations of 15.2 +/- 1.7 and 
22.6 +/- 5.1 nMol/liter. 
To verify removal of the binding protein from Sm-C, dilution curves 
using normal ovine plasma, acid-^treated ovine and bovine plasma, and 
ODS-silica column-extracted bovine plasma were tested. Normal ovine 
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plasma assayed at 12.5, 25 and 50 ul was parallel with the standard 
curve and had a mean concentration of 6.05 +/- 0.79 nMol Sm«C/liter. 
Acidified ovine plasma assayed at 12.5, 25 and 50 ul was parallel to the 
standard and had a mean concentration of 8.22 +/- 0.17 nMol/liter. 
Acidified bovine plasma samples from a heifer and bull, assayed at 25, 
50 and 100 ul, were parallel with the standard curve and had 
concentrations of 20.5 +/- 4.0 and 36.0 +/- 4.5 nMol/liter, 
respectively. The bovine samples extracted with the ODS column were 
also parallel with the standard curve and had concentrations of 18.4 +/-
0.80 nMol/liter for the heifer and 48.0 +A 8.5 nMol/liter for the bull. 
Addition of 8.75 nMol/liter of the standard to ovine plasma resulted in 
a recovery of 102%. The intra^ and inter-«assay coefficients of 
variation were 16% and 15%, respectively. 
In Exp. 1, four wethers (43 kg) were randomly assigned to a Latin 
square design with dose of GHRF as treatment. GHRF was administered at 
0, 0.05, 0.01, and 0.15 ug hpGHRF/kg body weight (bwt). Blood was 
collected 20, 10 and 1 min before and 5, 10, 15, 20, 40, 60, 80, and 100 
min after GHRF injection. In Exp. 2, four wethers (28 kg) were injected 
with 0.1 ug hpGHRF/kg bwt every 4 hr for 24 hr. Blood was sanpled 20, 
10 and 1 min before and 5, 10, 15, 20, 40, and 60 min after each GHRF 
injection. In Exp. 3, eight wethers (42 kg) were randomly assigned to a 
crossover design, with the animals receiving the buffer solution with or 
without 0.067 ug hpGHRF/kg bwt for 5 days. Animals were rested for 5 
days, and then treatments were reversed. Animals were injected every 4 
hr during the treatment periods. The first injection of GHRF was 12 hr 
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before the initiation of the collection period. Blood was sanpled daily 
20, 10 and 1 min before and 5, 10, 15, 20, 40, and 60 min after the 
afternoon injection 5 hr after feeding. 
Urine, feces, orts, and feed were collected for 5 days in Exp. 3. 
Samples of feed, orts, feces, and urine were collected daily, composited 
and stored at -15^C until analysis. Feed, orts and feces were chopped 
and then ground frozen in liquid nitrogen by using a heavy-duty blender 
(Waring, Model 32BL75, Waring Commercial, New Hartford, CT). Urine 
sanples were thawed, mixed, and an aliquot taken for chemical analysis. 
Nitrogen was determined by the Kjeldahl procedure using a Kjeltec System 
II (Tecator, Hoganas, Sweden) (14). Dry-matter contents of feed, ort 
and feces were determined by drying at 60*C (14). 
Analysis of variance was conducted using the Statistical Analysis 
System (15) for all experiments. Data from Exp. 1 were analyzed as a 
Latin square comparing ŒRF treatments. The experimental model in Exp. 
3 was a crossover design tested with animals nested within treatment. 
Growth hormone data were averaged into preGHRF (20, 10, and 1 min before 
GHRF injection), GHRF (5, 10, 15, and 20 min postinjection) and postGHRF 
(40, 60, 80, and 100 min after injection in Exp. 1 and 40 and 60 min 
after injection in Exp. 2 and 3) preceding final statistical analysis. 
32 
RESULTS 
Mean plasma GH responses to 0, 0.05, 0.1, and 0.15 ug l^GHRF/kg bwt 
are listed in Table 2. The pattern of response to GHRF in all 
experiments was a rapid rise in plasma GH peaking within 5 to 15 min 
postinjection, then declining to concentrations similar to preinjection 
within 40 min. The preGHRF and postGHRF GH concentrations were not 
different between treatments. During the GHRF period, only 50% of the 
sheep responded to the 0.05-ug dose, whereas all sheep responded to the 
0.1-«ug and 0.15^ug doses. The 0.1-'ug dose increased mean plasma GH from 
1.2 to 46.8 ng/tnl as compared with no increase in the animals injected 
with buffer alone (P<0.1). The 0.15-ug GHRF dose elevated GH to 31.9 
ng/tnl (P<0.13), which was not different from the response to 0.1 ug and 
suggesting that the peak of the dose titration curve was near 0.1 ug 
hpGHRF/kg bwt. 
In the second experiment, all sheep responded to each injection of 
0.1 ug hpGHRF/kg bwt given every 4 hr for 24 hr. The mean response is 
shown in Fig. 1. Insulin concentrations for the sheep ranged from 0.05 
to 1.02 ng/rnlf with a mean concentration of 0.44 ng/ml and a SB of 0.09. 
In these animals, 0.1 ug of GHRF/kg caused an increase in GH, which was 
considered to be above the normal physiological range for sheep. A dose 
of GHRF between 0.1 and 0.05 ug/kg bwt would .consistently obtain a GH 
response in all sheep of less than 40 ng/nl. The dose of 0.067 ug 
GHRF/kg bwt, which had previously been used for studies in cattle 
(16-17), was selected for the anabolic studies. 
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Table 2. Effects of increasing growth hormone-releasing factor on 
plasma growth hormone in sheep (Exp. 1) 
Period 
Dose PreGHRF^ GHRF° PostGHRF® 
ug GHRF/kg 
body weight Mean SE Mean SE Mean SE 
0 0.8 0.7 0.9 0.6 0.8 0.5 
0.05 1.2 0.6 4.6 3.1 1.3 0.8 
0.10 1.2 0.8 46.8 22.0 5.4 3.1 
0.15 1.4 0.6 31.9 15.4 3.5 1.9 
^ean of 20,  10 and 1 min before GHRF injection, 
^ean of 5, 10, 15 and 20 min after GHRF injection. 
Slean of 40, 60, 80 and 100 min after GHRF injection. 
Pulse injections of 0.067 ug GHRF/kg every 4 hr caused increases in 
plasma GH to concentrations ranging between 5 and 40 ng/ml. Plasma GH 
concentrations were elevated by GHRF in 36 of 40 (90%) of the injection 
periods sampled. Average GH responses are given in Table 3. There were 
no differences in preinjection GH concentrations between control and 
treated sheep. Mean response to GHRF at the 1500 hr injection was 16.4 
ng/ml compared with 2.3 ng/ml in control animals (P<0.01). 
Mean concentrations of plasma GH in response to intravaious 
injections of 0.1 ug (1-40)-OH t^QlRF/kg bwt in sl^ep every 4 
hr (n=4). Hie SE for the samples at 10 min before and after 
injection of CHRP are indicated by the bars. The times of 
feeding and GHRF administration are indicated by the arrows 
GHRF GHRF 
FEED 
GHRF 
FEED 
5 100 
80 
\ 
w U1 
08 09 12 13 16 17 20 21 24 01 04 05 08 09 
TIME (hours) 
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Table 3. Effect of growth hormone-releasing factor on plasma hormone 
concentrations (Exp. 3) 
Item Control GHï?F SE 
GH, (preGHRF) (ng/ml)3 2.7 2.3 0.4 
GH, (GHRF) (ng/ml)^ 2.3 16.4 3.9* 
Somatonedin-kz 
(nMol/liter) 14.0 15.7 1.6 
Insulin (ng/tal) 2.9 3.0 0.7 
Tri iodothyronine 
(ng/dl) 74.2 72.7 6.5 
Thyroxine (ug/dl) 18.1 18.2 1.1 
Cortisol (ug/dl) 1.7 1.6 0.2 
^Mean of 20, 10 and 1 min before injection. 
^Mean of 5, 10, 15, and 20 min after injection. 
*P<0.01. 
Urinary nitrogen decreased 2.9 g during the 5-day period (P<0.03) 
with injection of GHRF (Table 4). Fecal nitrogen (14 g, GHE*F versus 13 
g, control), intake nitrogen (86 g, GHRF versus 83 g, control), and 
dry-matter intake (5634 g, GHRF versus 5461 g, control) did not change 
with treatment. Even though nitrogen retention and weight gain 
increased 17% and 29%, respectively, in wethers given GHRF, these 
increases were not significantly different. Apparent digestibility of 
nitrogen and dry matter were not changed by GHRF. Apparent biological 
value of dietary protein and net protein utilization both increased 19% 
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with CHRP (P<0.2). Plasma urea nitrogen was 8% lower in animals given 
GHPF but was not statistically different from control values. 
Table 4. Effect of intravenous pulse injections of growth 
hormone-'releasing factor on nitrogen metabolism, weight gain 
and feed intake in sheep 
Item Control GHRF SE 
Urinary nitrogen, g/5 d 42.1 39.2 0.7* 
Nitrogen retention, g/5 d 27.5 32.3 3.5 
Plasma urea nitrogen, 
mg/dl 8.7 8.0 1.0 
Weight gain, g/5 d 482 624 310 
Dry-matter intake, g/5 d 5461 5634 195 
Apparent dry-^matter 
digestibility, % 72.6 76.0 2.0 
Apparent nitrogen 
digestibility, % 84.0 83.8 0.5 
Apparent biological value, % 37.0 44.0 3.0 
Net protein utilization, % 30.8 36.7 3.0 
*P<0.03. 
The concentrations of other metabolic hormones are listed in Table 
3. Although Sm«C concentrations increased 12% over the 5-day period 
with GHRF, the elevation was not significant. Insulin, 
triiodothyronine, thyroxine, and Cortisol were not affected by GHRF 
treatment. 
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DISCUSSION 
Growth hormone-releasing factor induced a plasma GH response in all 
our experimental animals. In the first experiment, GH was released in a 
dose-dependent manner. A similar dose->dependent relationship between 
GHRF administration and plasma GH response was obtained previously with 
sheep and cattle (16-^20). In all experiments, plasma GH peaked within 5 
to 15 min after injection of GHRF. The peak was followed by a return of 
GH to preinjection concentrations within 15 to 45 min. 
The ability of our experimental animals to respond to multiple 
injections of GHRF, by releasing Œ into the plasma, was danonstrated in 
Exp. 2 and 3. In the second experiment, in which GHRF was administered 
every 4 hr for 24 hr, all animals responded to every GHRF injection. In 
an extended study, in which GHRF was administered every 4 hr over a 
5-day period (Exp. 3), the sheep maintained their overall ability to 
release GH in response to exogenous GHRF. Every sheep, however, did not 
always respond to each GHRF administration with elevated plasma GH. Of 
the measured GH responses, the sheep responded to 85% of the injections. 
The capability to respond to exogenous GHE(F with repeated administration 
over time has also been observed in ruminants by Hart et al. (20), 
Moseley et al. (21-22), and Della-Fera et al. (23). Our results are in 
agreement with the findings of Hart et al. (20), who showed consistent 
plasma GH responses over 4 days of injecting GHRF every 2 
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hr in sheep. In contrast to these results, Della-'Fera et al. (23) 
reported that, after the initial injection of GHRF to sheep, the amount 
of GH released decreased with subsequent GHRF administration. They 
suspected that the declining GH response was due to a refractoriness 
occurring at the pituitary level. Some of the injections that were 
administered were not always effective in stimulating a GH response, but 
this has been observed in similar experiments with cattle (19, 24), pigs 
(25), rats, rabbits, and humans (26-27). In an attempt to explain the 
variation in effectiveness of GHRF to release GH, Jansson et al. (26) 
suggested that the inconsistency was due to physiologically competing 
events, such as feedback, from endogenous GHRF, GH, and Sm-C, or 
elevated levels of somatostatin, which is a noncompetitive inhibitor of 
GHRF. It has been reported that, when GHRF is administered during an 
exogenous pulse of GH, a higher plasma GH peak is observed than when 
GHRF is administered between GH peaks (28-29). Furthermore, Shibasaki 
et al. (30) demonstrated that, whai the interval between GHRF pulses was 
2 hr, the second injection was ineffective. Nevertheless, this study's 
results, overall, showed that GHRF induced a significantly elevated GH 
response in sheep when administered at a dose of 0.067 ug/kg bwt every 4 
hr. 
In the present study, it was found that GHRF administered 
intermittently over a 5-day period (Exp. 3) altered nitrogen utilization 
in sheep. Decreased urinary nitrogen excretion (P<0.03) occurred with 
GHRF treatment without affecting intake or fecal nitrogen. This 
resulted in 17% greater nitrogen retention as compared with control 
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animals. Similar results were obtained by Moseley et al. (22) with 
constant infusion of GHRF in calves for 20 days. They noted that, 
during days 9 to 14 of treatment, urinary nitrogen decreased 14% 
(P<0.02), whereas intake and fecal nitrogen were not affected by 
treatment. The 18% greater nitrogen retention in the GHRF treated 
calves, however, was significant (P<0.04). The plasma urea nitrogen of 
our sheep declined 8% with GHRF treatment. This is similar to the 
observations of Hart et al. (20), who administered GHRF to ewes every 2 
hr for 4 days and observed a 3.5% reduction in plasma urea nitrogen. 
Elevated levels of plasma Sm-€ have been associated with enhanced 
growth rates in ruminants (31), suggesting a positive relationship 
between growth and Sm-'C. Although the 12% increase in Smk] in 
GHRF-treated sheep was not significant, the rise in Sm-C along with a 
significant decline in urinary nitrogen and enhanced nitrogen retention, 
biological value, and weight gain, suggested that growth was occurring 
at an accelerated rate with GHRF treatment. 
Growth responses, such as enhanced nitrogen retention or increased 
tibia length, have beai known to depend on frequency of GH 
administration (32-33). The most effective pattern of GH that promotes 
growth of rats seems to be an intermittent plasma GH pulse with low 
intervening GH levels (26, 34-35). Similarly, in experiments with GHRF, 
Clark and Robinson (1) found that pulse injections administered every 3 
hr for 12 days, accelerated body growth in female rats and male rats 
with GHRF deficiency, whereas continuous infusion had no effect on 
growth. The superiitçosed male GH pattern created by exogenous GHRF in 
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female rats promoted an Increase of 30% in body weight gain over control 
rats. In addition, pituitary GH content was increased by pulsatile but 
not continuous infusion of GHRF. Frohman and Jansson (27) postulated 
that intermittent exposure to a small dose of GHEŒ* caused a more 
favorable GH synthesis-release ratio than constant GHW exposure, 
resulting in larger readily releasable pools of GH in pituitaries. In 
our experiment, we found that GHRF administered as a pUlse every 4 hr 
for 5 days decreased the urinary nitrogen losses from the body, 
suggesting that GHRF was stimulating growth responses. Multiple 
injections of GHRF did not alter the baseline of plasma GH in either 
Exp. 2 or 3, which is consistent with a GH pattern known to stimulate 
rapid growth in rats (34-35) and ruminants (8*9). 
The present study demonstrated that intermittent intravenous 
injections of GHRF were able to release GH in sheep within the normal 
range of their plasma GH over extended periods. Although only 
conservation of urinary nitrogen was significant, all the other 
measuranents suggested that there was an anabolic response to GHRF in 
sheep. These experiments suggested that pulsatile administration of 
GHRF could be used to increase growth rates in domestic sheep. 
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SECTION II. GROWTH HORMONE-RELEASING FACTOR AND 
SOMATOSTATIN Œ GROWTH HORMONE 
SECRETION IN PREPUBERTAL CALVES 
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ABSTRACT 
The effects of intravenous (iv) administration of growth 
horroone->releasing factor (GHGF) and somatostatin (SRIH) on growth 
hormone (GH) secretion and ŒRF on nitrogen metabolism were measured in 
prepubertal calves. Crossbred beef heifers (111 kg) were used in a 
Latin square design to test the effects of 0, 0.01, 0.033, 0.067, and 
0.1 ug (1^40)-OH human pancreatic (hp) GHRF/kg body weight (bwt) on 
plasma GH concentrations. When they were given doses of 0.067 and 0.1 
ug hpGHRF/kg bwt, plasma GH increased (P<0.05) within 5^15 min, compared 
with injections of control buffer, and then returned to preinjection 
levels. The response to 0.067 ug (1^40)^OH hpGHRF/kg bwt injected every 
3 hr for 42 hr was studied in five heifers (137 kg bwt). The animals 
responded to 20 of 40 hpGHRF injections during the sanpling periods. 
They only responded to one of the two GHRF injections with an increase 
in plasma GH during every â-^hr period measured. In two heifers (183 kg 
bwt) given 0.067 ug (1-40)-OH hp GHRF/kg bwt during infusions of 0.033 
and 0.067 ug SRIH (SS)-14/(kg bwt*min) for 70 min, SRIH suppressed the GH 
response to the GHRF. Nitrogen retention and weight gain were measured 
in five bull calves (90 kg bwt) administered 0 or 0.067 ug [Nle^?] 
(1-29)-NH2 rat hypothalamic (rh) GHRF/kg bwt every 4 hr for 10 days. 
Although increases of 16% in nitrogen retention and 36% in weight gain 
with pulsatile GHRF treatment were variable and statistically similar to 
those of controls, these and other metabolic parameters were interpreted 
to indicate an anabolic response to GHRF. These results indicate that 
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GHRF induces peak GH secretion within 15 min in prepubertal calves, that 
the secretion of GH is suppressed by iv infusion of SRIH, and that GHRF 
may be anabolic in prepubertal calves under different regimens of 
peptide administration. 
49 
INTRODUCTION 
Hypothalamic regulation of growth hormone (GH) secretion is 
mediated by a stimulatory factor, growth hormone'^releasing factor 
(CHRP), and an inhibitory factor, growth hormone-releasing-inhibiting 
hormone, somatostatin (SRIH). Administration of GHRF results in a pulse 
release of GH into the plasma, creating a spike similar to that of 
endogenous GH secretion. It has been suggested that this episodic 
pattern of GH secretion is in^rtant in the regulation of growth (1, 2). 
There are also age-related changes in GH secretion in cattle, in which 
the secretion of plasma GH declines as the animals age (3). To 
understand the role of GH regulation in controlling growth, 
investigations are needed to determine the response of young ruminant 
animals to exogenous releasing and inhibiting GH peptides. 
The objective of this study was to determine the role of GHRF on 
the secretion of GH in prepubertal calves by studying the effects of 
GHRF on GH secretion, the changes in plasma GH with multiple injections 
of GHRF, the interaction of exogenous GH^release-inhibiting hormone, 
somatostatin (SRIH), and GHRF on GH secretion, and the effect of 
pulsatile GHRF administration on nitrogen metabolism in calves. 
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MATERIALS AND METHODS 
Animals 
Crossbred beef heifer calves individually penned with straw bedding 
in an environmentally controlled roan at IS'C with 12^hr photoperiods 
were used in Exp. 1, 2 and 3. In Exp. 4, five Hoistein bull calves were 
maintained under similar conditions^ although they were adjusted to 
metabolism crates for 3 wks before the experiment. Calves were fed the 
diets described in Table 1 at 12^hr intervals unless otherwise 
indicated. An indwelling catheter (Tygon microbore tubing, 1.27 ram 
i.d.. Fisher Scientific, Pittsburgh, PA) was inserted in a jugular vein 
at least 1 day before experimentation. The catheters were filled with 
sterile saline containing 100 U heparin/ml between experiments and with 
sterile saline with 40 U heparin/ml when blood samples were being taken. 
Blood sangles were treated with heparin (4 U/ml), and plasma was stored 
at -IS'c until analyzed. All sanples were analyzed for GH (4). The GH 
assay had intra-» and inter-assay coefficients of variation of 1.7% and 
9.0%, respectively. 
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Table 1. Composition of diets (dry-matter basis) 
Experiment 1,2,3 
% 
4 
% 
Com, cracked 49.0 45.0 
Alfalfa, dehydrated 39.0 39.0 
Soybean meal, solvent 
extracted 5.6 9.5 
Molasses, cane 5.6 5.6 
Dicalcium phosphate 0.5 0.4 
Salt, iodized 0.2 0.2 
Trace mineral 0.02 0.02 
Vitamin A (5,2 million lU/kg) 0.1 0.09 
Peptides 
Animals received bolus intravenous (iv) injections of human 
pancreatic (hp) (1-40)-OH OiRF in Exp, 1-3 (5) and [Nle^?] (1-29)-NH2 
rat hypothalamic (rh) GHRF in Exp, 4 (6). Scmatostatin (SS)^14 (SRIH) 
was administered iv by continuous-infusion punps (Harvard, Model 1201, 
Harvard Apparatus, Millis, MA), The GHRF and SRIH were dissolved in 
0,1% acetic acid (1 ug/ul) and then diluted with a sterile buffer 
solution. The buffer was physiological saline (0,818% NaCl) containing 
0,01 M NaH2PO^*H20, pH 7,0, 0,01% ascorbic acid, and 1% bovine serum 
albumin. Solutions for injection and infusion were prepared the day of 
exper imentation, 
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Dose Titration (Exp. 1) 
Five 4-mo^old heifers (111 kg bwt) were randomly assigned to a 
Latin square design to test the plasma GH response to 0, 0.01, 0.033, 
0.067, and 0.1 ug ŒRF/kg bwt. Blood samples were collected 20, 10 and 
1 min before injection and 5, 10, 15, 20, 4Gf, 60, 80, 100, and 120 min 
after injection. Animals were fed the evening before the experiment and 
were allowed several hours to eat before the feed was removed. 
Multiple Injections (Exp. 2) 
Five 5-^o-old heifers (137 kg bwt) were randomly assigned to a 
crossover design testing 0 or 0.067 ug hpGHRF/kg bwt administered at 
3^hr intervals for 42 hr. The treatments were reversed, and the 
experiment repeated after 1 v^. In order to monitor acute GH changes in 
response to GHRF after multiple injections, blood was sampled during 
four periods of 5 or 6 hr during the 42 hr to monitor plasma Œ 
concentrations. During the 8-hr intervals that were not monitored for 
plasma GH, the calves received GHRF at 3-hr intervals. Two injections 
of GHRF were administered during each of the four sampling periods. 
Within each sanpling period, the animals were fed between the GHRF 
injections. Blood was collected at 20-min intervals except immediately 
after a GHRF injection, when they were taken at 5-min intervals for 20 
min. 
SRIH and GHRF (Exp. 3) 
Two heifers (183 kg bwt) at 6 mo of age were infused with 0.033 or 
0.067 ug SRIH/(kg bwt*min) for 70 min in a crossover design. After 30 
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min of SRIH infusion, 0.067 ug GHRF/kg bwt was administered iv as a 
bolus injection. Plasma was sampled 30, 15 and 1 min before SRIH 
infusion; 15, 29, 35, 40, 45, 50, and 70 min during SRIH infusion and 
GHRF injection; and 90, 110, 130, and 150 min after SRIH infusion. The 
animais were fed in the morning, and the experiments conducted in the 
afternoon. 
Nitrogen Balance (Exp. 4) 
Five Holstein bull calves at 3.5 mo of age (90 kg bwt) were 
assigned randomly to a crossover design to test the effects of 
administration of GHRF or control buffer every 4 hr for two consecutive 
5-day periods on nitrogen metabolism. They received 0 or 0.067 ug 
[Nle27] (1-29)-NH2 rhGHRF/kg bwt via a jugular catheter at 4-hr 
intervals. After the 10-day period, the animals were rested for 7 days; 
then treatments were reversed. Blood was sampled once daily for 80 min 
surrounding the afternoon GHRF injection, as well as 20, 10 and 1 min 
before injection and 5, 10, 20, 40, and 60 min after injection. 
In addition to GH, all plasma samples from Exp. 4 were analyzed for 
insulin (7), plasma urea nitrogen (Micro-urea, Technicon-N-'10a, 
Autoanalyzer), and plasma glucose (Worthington Flozyme Glucose, 
Worthington, Diagnostic Systens, Inc., Freehold, NJ). Intra- and 
inter-assay coefficients of variation for the insulin assays were 1.1% 
and 1.3%, respectively. Coefficients of variation for plasma urea 
nitrogen were 5.8%, intraassay, and 7.3%, interassay. Plasma glucose 
intraassay coefficient of variation was 3.1%, whereas interassay 
coefficient of variation was 7.1%. The plasma saitples taken before GHRF 
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injection were pooled for each day for analysis of somatomedin-C (Ininuno 
Nuclear Corp.y Stillwater, MN, as modified by Plouzek and Trenkle (8), 
triiodothyronine (Amerlex T-^3 RIA kit, Amersham Corp., Arlington 
Heights, IL), thyroxine (Amerlex T-^4 RIA kit, Amersham Corp., Arlington 
Heights, IL), and Cortisol (Cortisol Double Antibody, Diagnostics 
Product Corp., Los Angeles, CA). The pooled samples were analyzed in 
one assay. The resulting intraassay coefficients of variation were 1.9% 
for somatomedin-C, 1.5% for thyroxine, 1.8% for triiodothyronine, and 
1.4% for Cortisol. 
Sangles of feed, feces, urine, and orts were collected daily, 
composited over 5 days and stored at -15"C until analysis. Feed, feces 
and orts were chopped and then ground frozen in liquid nitrogen by using 
a heavy duty blender (Waring, Model 32BL75, Waring Commercial, New 
Hartford, CT). Urine sanples were thawed and mixed, and an aliquot was 
removed for chemical analysis. Nitrogen was determined by the Kjeldahl 
procedure (9) using a Kjeltec System II (Tecator, Hoganas, Sweden). 
Dry-imatter contents of feed, orts and feces were determined by drying at 
60°C (9). 
Statistical Analysis 
GH concentrations before GHRF injection (20, 10 and 1 min) were 
averaged, as well as 5, 10, 15, and 20 min after GHRF injection and 40, 
60, 80, 100, and 120 min after GHRF injection for statistical analysis 
in Exp. 1. The means were analyzed as a Latin square design with dose, 
period and animal as main effects (10-11). The GH data in Exp. 2 were 
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analyzed as a crossover design with treatment (0 or 0.067 ug GlRFAg 
bwt) and animal as main effects (10^11). 
The experimental units in this study were the individual calves. 
Daily concentrations of somatomedin^C, triiodothyronine, thyroxine, 
Cortisol, plasma glucose, and plasma urea nitrogen in Exp. 4 were 
averaged before statistical analysis. The model used to test the 
crossover design in Exp. 4 was animal nested within treatment as the 
error term to test treatment and period effects. 
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RESULTS 
Dose Titration 
Plasma GH increased in a dose-dependent manner, with a peak 
occurring between 5^15 min after injection of hpGHRF, and then it 
declined rapidly to basal levels within 60 min (Fig. 1). One animal did 
not respond to. any dosage of GHRF. Overall, the animals responded to 
66% of the GHRF injections. Before injection of GHRF, Œ averaged 5.5 
+A 1.2 ng/ml (+/•' SE). During the first 20 min after injection of 
GHRF, GH averaged 7 +/- 1.9, 19 +/- H, 20 8, 43 +/- 17, and 54 +/-
17 ng/ml for 0, 0.01, 0.033, 0.067, and 0.1 ug GHRF/kg bwt, 
respectively. GH levels during the 20-min period after injection of 
0.067 (P<0.05) and 0.1 ug GHRF/kg bwt (P<0.025) were greater than those 
of controls. Mean GH for all treatments at 40-120 min after GHRF 
injection was 6 +/* 1.9 ng/ml. 
Multiple Injections 
The pattern of GH release in response to injections of 0.067 ug 
hpGHRFAg bwt every 3 hr for 42 hr, as shown in Fig. 2, was similar to 
that observed in Exp. 1. Of the 20 responses, 12 occurred after the 
first GHRF injection, and 8 responses were observed after the second. 
Each animal responded to only one of the two injections in a 5-'hr 
sampling period. Three animals responded to the first injection of 
GHRF, but they did not respond to GHRF after feeding. The injection to 
which a given animal responded remained consistent 
Fig. 1. Mean concentration of plasma GH in crossbred beef calves in 
response to intravenous injections of 0, 0,01, 0.033, 0.067, 
and 0.1 ug (1-40)-OH l^)GHRF/kg bwt (n=5). The dose of QIRF is 
indicated above the arrow at the time of administration. 
Representative SE for the samples at 10 min before and after 
injection of QWF are indicated by the bars 
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Fig. 2. "Rie average plasma GH concentrations of calves receiving 0 or 
0.067 ug (1-40)-(M l^>GHRFAg bwt at 3^hr intervals for 42 hr. 
The thick line illustrates the response of animals receiving 
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throughout the experiment with two exceptions: 1) One animal responded 
to both injections of GHRF in one period, and 2) one animal did not 
respond to GHRF during one sanpling period. Hie average GH response 
within the four sançling periods to the first GHRF injection was 37 +/-' 
20 ng/ml and 22 +/- 16 ng/ml to the second GHRF injection. The response 
to GHRF during sampling periods was the same. The overall GH mean was 3 
+/- 2.0 ng/ml for control animals. 
SRIH and GHRF 
After a preliminary study to determine effective doses of SRIH 
infusion to suppress GH secretion in calves, 0.033 and 0.067 ug SRIH/(kg 
bwt*min) were infused for 70 min and 0.067 ug hpGHRF/kg bwt was injected 
iv as a bolus 30 min after these infusions began (Fig. 3). GH averaged 
9 +/^ 1.2 and 13 +/^ 2.0 ng/nnl before infusion of 0.033 and 0.067 ug 
SRIH, respectively. During SRIH infusion, basal GH declined to 8 +/-
0.3 and 9 +/- 0.7 ng/nl for the 0.033 and 0.067 ug SRIH doses. When 
GHRF was injected during the 0.033 ug SRIH infusion, GH increased to 16 
+/- 5.4 ng/ml; concomitantly, the GH response to GHRF during infusion of 
0.067 ug SRIH was 14 +/- 1.6 ng/ml. When the SRIH infusions were 
stopped, GH was released as a spike, with mean concentrations of 15 and 
12 ng/ml for the 0.033 and 0.067 ug SRIH doses, respectively (Fig. 3). 
Fig. 3. Mean concentrations of plasma GH in calves being infused with 
0.033 or 0.067 ug somatostetin (SS)«14 (SRIH)/(kg bwt*min) and 
injected with 0.067 ug (1-40)-(*1 IqtGHRFAg bwt (n=2). Arrows 
illustrate the time of GHRF injection, and the hatched area 
indicates the period of SRIH infusion 
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Nitrogen Balance 
Mean concentrations of plasma hormones in animals injected with 
buffer or GHRF for 10 days are given in Table 2. Since the S^^day 
periods did not differ from each other, the 10-<day means are presented. 
The mean GH response in animals given GHRF was 25 ng/ml (P<0.05), 
compared with 7 ng/tnl in control calves. "Hie calves responded to 46 
(77%) of the 60 GHRF injections in which sequential blood samples were 
obtained. The amplitude of the GH response to GHRF was similar to the 
beginning and end of the 10-iday period. GH averaged 6.5 and 8.7 ng/ml 
before injections of GHRF and buffer. Although concentrations of 
somatcmedin-C were 23% greater in calves given GHRF, these differences 
were not statistically significant. Insulin, triiodothyronine, 
thyroxine, and Cortisol were not altered with administration of GHRF. 
Although nitrogen retention increased 16% in calves given GHRF, it 
was not different (P>0.05) from that of controls. Urinary, fecal and 
intake nitrogen did not significantly change with GHRF treatment (Table 
3). However, nitrogen intake increased 12% and urinary nitrogen 
increased 4%, which, by calculation, caused a 3% decrease in the 
percentage of intake nitrogen excreted in the urine with GHRF treatment. 
Apparent nitrogen digestibility and biological value were not affected 
by GHRF treatment. Plasma urea nitrogen, which declined 6% with GHRF 
treatment, and glucose were not signficantly different between 
treatments. Although body weight gain increased 36% with GHRF 
administration, the increase was not significant. Dry-matter intake 
also increased 14%, but it was not statistically different from control 
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values. Fecal dry matter and dry-matter digestibility were not altered 
by GHRF treatment. 
Table 2. Effect of multiple injections of GHRF on plasma hormone means 
over 10 days (Exp. 4) 
Control GHRF SE 
GH, ng/ml® 8.7 6.5 1.5 
GH, ng/ml^ 7.0 25.1° 8.0 
01, ng/ml*^ 7.8 9.8 1.8 
Somatomedin-C, nMol/liter 6.6 8.1 2.4 
Insulin, ng/ml 0.51 0.54 0.12 
Triiodothyronine, ng/dl 1.34 1.31 0.22 
Thyroxine, ug/dl 7.4 7.7 1.1 
Cortisol, ug/dl 1.8 2.2 0.3 
^ean of 2 0 ,  10 and 1 min before GHRF injection. 
4^ean of 5, 10, 15, and 20 min after GHRF injection. 
/^Mean significantly different (P<0.05) from corresponding control 
mean. 
'^ean of 40 and 60 min after GHRF injection. 
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Table 3. Effect of multiple injections of GHRF on nitrogen metabolism, 
weight gain and feed intake (Exp. 4) 
Control GHRF SE 
Nitrogen intake, g/10 day 274 306 53 
Urinary nitrogen, g/10 day 93.8 97.5 10.5 
Apparent nitrogen digestibility, 
% 90.0 91.2 0.4 
Nitrogen retention, g/10 day 156 181 41 
Agirent biological value, % 60.4 63.5 4.9 
Intake nitrogen excreted 
in urine, % 35.9 33.2 4.4 
Plasma urea nitrogen, mg/dl 6.9 6.5 0.8 
Plasma glucose, mg/dl 90.3 94.3 5.3 
Weight gain, kg/10 day 1.95 2.66 0.79 
Dry-matter intake, kg/10 day 11.0 12.5 2.2 
Apparent dry-matter 
digestibility, % 69.1 69.0 1.5 
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DISCUSSION 
Prepubertal calves responded to GHRF in a dose-dependent manner and 
to multiple injections of GHRF without a decline in peak amplitude of 
GH. These results are similar to studies with cattle and sheep (8, 
12-«15). In contrast, prepubertal lambs given multiple injections of 
GHRF declined in their Œ response over 3 days (16). 
Five-'mo-^old calves receiving GHRF every 3 hr for 42 hr responded to 
50% of the GHRF injections measured (Exp. 2), whereas a greater degree 
of responses (77%) was observed in 3.5%o'-old calves given GHRF every 4 
hr for 10 days (Exp. 4). A similar lack of response to some GHRF 
injections has been observed in studies with cattle and sheep (8, 13, 
17), pigs (18, 19), rats (20), rabbits, and humans (21, 22). Hie 
response to GHRF may be related to physiological events occurring during 
GHEŒ* administration, such as secretion of hypothalamic SRIH. 
Prepubertal calves were sensitive to SRIH administration. The GH 
response to GHRF was blunted vAien SRIH was continuously infused. When 
the calves were given 0.067 ug hpGHRF/kg bwt without SRIH, mean GH 
increased to 28 ng/ml. This response declined to 16 ng/ml (41% 
suppression) when 0.033 ug SRIH/kg bwt was infused. This is similar to 
results with rat somatotrophs cultured with GHE*F and SRIH simultane­
ously, in which GH secretion was reduced in comparison with GHRF in the 
absence of SRIH. Furthermore, increasing doses of SRIH resulted in a 
concomitant decrease in GH release stimulated by GHRF (23-24). In this 
study, after SRIH infusion in the calves, GH rebounded to levels 
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comparable to the GHRF-induced release of GH. A similar increase in GH 
release after withdrawal of SRIH has been observed with cultured 
somatotrophs (25-27). Kraicer et al. (27) demonstrated that the 
amplitude of the GH rebound after withdrawal of SRIH increased if GHRF 
was administered with SRIH. 
Administration of 0.067 ug hpGHRF/kg bwt every 4 hr for 10 days to 
90-kg calves increased nitrogen retention 16%, but this difference was 
not statistically significant. Although the endocrine and metabolic 
data were not significantly altered by GHRF treatment^ the changes in 
the values indicated that a minor anabolic effect may be occurring in 
the calves. These results may be compared with the observations of 
Moseley et al. (12) where heavier calves, continuously infused with 2.5 
ug (1-44)-NHj hpGHRF/tnin for 20 days, had an 18% increase in nitrogen 
retention and a 14% decline in urinary nitrogen on days 9-14. Similar 
to our study, they observed no significant changes in feed intake or 
protein digestion (12). The results of the present study may be 
contrasted with those in adult sheep, in which they were given the same 
dose of 0.067 ug GHRF/kg bwt at 4«hr intervals as the young calves in 
this study (8). "Aie sheep given GHRF had a significant decrease in 
urinary nitrogen, which was not observed in these calves. The 
dissimilar effect of GHRF when administered in the same manner in these 
two studies may result from differences between the two species, fewer 
experimental units in the calf trial or differences due to age of the 
animals in as much as younger animals secrete more GH than do adults 
(28). The difference in the pattern of secretion of GH by the younger. 
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rapidly growing animals may have caused their limited ability to achieve 
additional growth pulsatile administration of physiological dosages 
of GHRF. 
In conclusion, prepubertal calves were sensitive to exogenous GHRF 
and responded by repetitive release of GH similar to that of adults. 
These calves responded to exogenous SRIH by suppression of GH secretion 
and a blunted GH response to GHRF. Although the nitrogen retention in 
calves increased 16% and weight gain was enhanced 36% in response to 
GHRF pulsed at 4^hr intervals for 10 days, the variation between animals 
prevented these increases froti acquiring significance. 
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SECTION III. EFFECTS OF GROWTH HORMCMS-RELEASING 
FACTOR AND SOMATOSTATIN CM GROWTH 
HORMONE SECRETION IN HYPOPHYSIAL 
STALK-TRANSECTED BEEF CALVES 
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ABSTRACT 
The effects of growth hormone-releasing factor (GHRF) on growth 
hormone (GH) secretion were studied in beef calves after hypophysial 
stalk transection (HST). Peripheral Œ concentration during surgery was 
elevated for 60 min after the initiation of anesthesia (to 15 ng/nl), 
which was greater than plasma levels after HST and during the recovery 
period (0-30 hr mean, 3 ng/nl; P<0.05). Episodic GH secretion normally 
seen in sham-operated controls (SOC) was abolished after HST. HST 
calves responded to every challenge of GHRF with an increase in plasma 
GH. A dose of 0.067 ug human pancreatic (hp) (1-40)-OH GHRF/kg body 
weight (bwt) 3 days after HST increased plasma GH to 55 ng/ml from a 
control period mean of 5 ng/ntil (P<0.04). On day 8, HST calves received 
two injections of 0.067 ug t^HRF/kg bwt at 3-hr intervals, with feeding 
70 min after the first injection. During the preinjection control 
periods, basal GH averaged < 4 ng/tnl and increased to 17 (P<0.02) and 9 
(P<0.04) ng/ml immediately after the first and second injections of 
hpGHRF. On days 19 and 20, HST calves were infused iv with 0.033 and 
0.067 ug somatostatin(SS)-i 14 (SRIH)/(kg bwt*min), during which a pulse 
injection of 0.067 ug hpGHRFAg bwt was administered. GH increased to 9 
and 5 ng/ml during the 0.033- and 0.067-ug SRIH infusions after GHRF; no 
somatotropic rebound was observed after the SRIH was discontinued. Five 
and six months after HST, the responses to two analogs of rat 
hypothalamic GHRF were similar to those in SOC calves. These results 
indicate that HST calves responded to exogenous stimuli of GHRF with an 
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abrupt increase in plasma GH, but GH response to GHRF during SRIH 
infusion was severely inhibited. 
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INTRODUCTION 
The hypothalamus regulates episodic growth hormone (GH) secretion 
from the pituitary by release of growth hormone-»releasing factor (GHRF) 
and growth hormone-releasing-inhibiting hormoney somatostatin (SRIH). 
The neurohypophysial link between the hypothalamus and pituitary for 
these releasing and inhibiting hormones is the hypophysial stalk. After 
surgical hypophysial^stalk transection (HST), normal episodic secretion 
of GH is abolished in cattle and pigs (1^ 2) and these animals have 
depressed growth rates (3). Unlike hypophysectomized animalsy HST 
animals can serve as a model to study the isolated effects of brain 
releasing and inhibiting hormones on pituitary hormone secretions. It 
is known that GHRF can stimulate an endogenous GH release in man, rats, 
pigs, sheep, and cattle (4-6). The effects of GHRF on GH release in HST 
animals, however, have not been reported. The purpose of this study was 
to investigate the effects of GHRF on GH release as a single- or 
multiple-pulse dose, to verify that the pituitary would respond to other 
exogenous stimuli, and to examine the interactions of GHRF and SRIH in 
prepubertal HST calves. 
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MATERIALS AND METHODS 
Animals 
Five crossbred beef heifers were individually penned with straw 
bedding in an environmentally controlled room at 18*C with 12^hr 
photoperiods. They were fed at 12-hr intervals a diet consisting of 49% 
cracked com, 39% dehydrated alfalfa, 5.6% sol vent''extracted soybean 
meal, 5.6% cane molasses, 0.5% dicalcium gAiosphate, 0.2% iodized salt, 
0.02% trace mineral, and 0.1% vitamin A (5.2 million lU/kg)« Animals 
were fed in the morning, and experiments conducted in the afternoon. An. 
indwelling catheter (Tygon microbore tubing, 1.27 ram i.d.. Fisher 
Scientific, Pittsburgh, PA) was inserted in a jugular vein before 
surgery and maintained for all experiments. The catheters were filled 
with sterile saline containing 100 U heparin/tnl between experiments and 
with sterile saline with 40 U heparin/uL when blood samples were being 
obtained. Blood samples were treated with heparin (4 U/ml), and the 
plasma was stored at •^15'*C until radioimmunoasay for GH (7). The GH 
assay had intra- and inter-assay coefficients of variation of 1.7% and 
9.0%, respectively. 
Peptides 
Animals received bolus intravenous (iv) injections of human 
pancreatic (hp) (1-40)-OH GHRF (8), (1-32)-OH rat hypothalamic (rh) 
GHRF, [Nle^?] (1-29)-NHgthGHRF (9), and thyrotropin-releasing hormone 
(TRH, Sigma Chemical Co., St. Louis, MO). Somatostatin(SS)-14 (SRIH) 
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was administered iv by continuous-^infusion pumps (Harvard, Model 1201, 
Harvard Apparatus, Millis, MA). The GHRF, TRH and SRIH were dissolved 
in 0,1% acetic acid (1 ug/ul) and then diluted with a sterile buffer 
solution. The buffer was physiological saline (0.818% NaCl) containing 
0.01 M NaH2P0^*H20, pH 7.0; 0.01% ascorbic acid; and 1% bovine serum 
albumin. Solutions for injection and infusion were prepared the day of 
experimentation. 
Surgery 
Commencing 3 hr before anesthesia and surgery and continuing 
throughout surgical intervention, blood was sanpled at 15-min intervals. 
Subsequently, blood was sanpled hourly for 5 hr, then at 6-hr intervals 
for 30 hr. HST was performed on five calves by a supraorbital approach 
described previously (10^11). Two sham^operated controls (SOC) were 
subjected to the same surgical procedures, with the exception that the 
hypophysial stalk was not severed. Anesthesia was induced by iv 
injection of thianylal sodium (0.5-1.0 g, Surital, Parke-Davis, Morris 
Plains, NJ) and maintained by a closed-circuit system of halothane 
(1-4%, Ayerst Laboratories, New York, NY) and 0^ (400-800 ml/tnin). 
After the hypophysial stalk was severed, a nylon disc (8.0 mm diameter 
and 0.45 mm thickness) was inserted between the severed ends of the 
tubular stalk to prevent regeneration between the hypothalamus and 
pituitary gland. Water and food intake returned to normal 6-24 hr after 
surgery. Postmortem examination of each heifer confirmed the 
completeness of stalk transection, the nylon disc was in the proper 
location and had prevented vascular regeneration of the stalk in each 
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calf. The pituitary gland was cut transversely and fixed in Susa's 
solution for histological evaluation. The glands were sectioned at 6 um 
and stained with perforraic acid-Alcian blue-aperiodic acid«Schiff-orange 
G ty the method of Heath (12), whereas other sections were stained with 
hematoxylin and eosin. 
hpGHRP Dose Response (Exp. 1) 
Three and four days after surgery, the HST calves (170 kg) received 
0.067 and 0.133 ug hpGHRF/kg bwt, respectively, to test the GH secretory 
response. Plasma samples were collected 20, 10 and 1 min before the 
saline control period; 5, 10, 15, 20, 40, and 60 min during the control 
period; and 5, 10, 15, 20, 40, 60, 80, 100, and 120 min after GHRF 
injection. 
TRH Response (Exp. 2) 
Five days after surgery, the HST calves were injected iv with 100 
ug TRH. Plasma sampling was similar to that in Exp. 1. 
Multiple Injections of GHRF (Exp. 3) 
Eight days after surgery, the HST calves received two iv injections 
of 0.067 ug hpGHRF/kg bwt at 3^hr intervals, with feeding 70 min after 
the first GHRF injection. Plasma was sampled at 20-min intervals before 
the first GHRF injection and at 5-min intervals for the first 20 rain 
after GHRF injection and then sanpling at 20-min intervals thereafter. 
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SRIH and GHRF on GH Secretion (Exp. 4) 
Nineteai days after surgery, two HST calves (183 kg) were infused 
with 0.033 or 0.067 ug SRIH/(kg bwt*min) for 75 min in a crossover 
design. After 30 min of SRIH infusion, 0.067 ug hpGHRF/kg bwt was 
administered iv as a bolus injection. Plasma was sampled 30, 15 and 1 
min before SRIH infusion; 15, 29, 35, 40, 45, 50, and 70 min during SRIH 
infusion and GHRF injection; and 90, 110, 130, and 150 min after SRIH 
infusion. 
rhGHRF Dose Response (Exp 5) 
Five mo after surgery, the GH response to [Nle^?] (1-29)-NHj rhOiRF 
was compared in three HST calves (245 kg bwt) and two SOC calves (304 
kg bwt). The doses tested were 0, 0.0083, 0.0165, 0.033, 0.067, and 
0.133 ug rhGHRF/kg bwt. Plasma was collected 20, 10 and 1 min before 
injection and 5, 10, 15, 20, 40, 60, 80, 100, and 120 min after 
injection. The experiment was repeated at 6-mo after surgery using the 
same dosages of another analog, rhGHRF(1-32)-OH. 
Statistical Analysis 
The experimental units in this study were the individual calves. 
Data were analyzed ly using the Student's "t" test for comparisons among 
treatment groups (13-14). 
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RESULTS 
GH secretion in these animals is presented: 1) during presurgery 
and anesthesia, and the effects of HST and SOC during the first 30 hr 
after surgery as seen in Fig. 1; 2) comparisons of pre^ and post-GHRF or 
TRH treatments in HST calves as seen Figs. 3^5; and 3) comparisons of 
ŒRF treatment during SRIH infusions before and after HST as seen in 
Pig. 6. 
Surgery 
In the seven calves subjected to either HST or SOC, the plasma GH 
levels during surgery and immediately in the postoperative recovery 
period are depicted in Fig. 1. GH secretion during the preanesthesia 
period, 9 +/- 3.9 ng/inl (+/- SE), (mean values from -345 to -195 min) 
was variable and similar to that during surgery and postoperative 
recovery period. The first 60 min after the initiation of anesthesia 
(-180 to =135 min), peripheral GH increased to a mean of 15 +/<: 4.6 
ng/ml, which was greater than in SOC calves during the first 90 min 
after time zero (3 +/•* 0.7, P<0.05) as well as all the periods (P<0.05) 
following time zero in the HST calves (0-90 rain, 4 +/- 0.8 ng/ml; 2-5 
hr, 2.5 +/-^ 0.8 ng/ml; 6-30 hr, 3 +/-« 0.8 ng/ml). A postanesthesia GH 
surge occurred at 3-4 hr in the SOC calves, which was greater than that 
in the HST calves (10 +/- 1.8 vs 3 +/-* 1.0 ng/ml; P<0.05). 
t-'ig. 1. Plasma Œ concentrations in beef calves before and after 
surgery are illustrated. The GH re^>onse indicated the open 
circles (o) illustrates the period before surgical 
intervention, which is indicated by the opai arrow (n=7). 
Plasma GH after hypothalamic-stalk transection (HST) is 
illustrated by closed triangles (A) (n=5), and GH after 
sham-operated controls (SOC) is indicated by squares (a), 
(n=2). Values are the mean +/- SE. SE bars for samples taken 
2 and 3 hr after surgery are within the symbol 
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Histology 
Histological examination of pituitary glands from HST calves 
indicated the persistence of at least some secretory cells in the same 
areas of the adenohypophysis as in SOC calves (Fig 2). In sections from 
HST and SOC calves stained with performic acid->Alcian blue^periodic 
acid-^Schiff-orange G, acidophils^ basogAiilSy and chromophobes were 
present. Pituitary gland weight was 35% less (P<0.01) in HST (0.91 +/-
0.05 g; 0.2 +/- 0.01 g/100 kg bwt) compared with SOC (2.59 +/- 0.20 g; 
0.6 V 0.03 g/100 kg bwt) calves. 
hpGHRF Dose Response (Exp. 1) 
The HST calves responded to 0.067 and 0.133 ug hpGHRF/kg bwt with a 
rapid increase in plasma GHy which peaked within 10-20 min and then 
declined to preinjection concentrations within 60 min (Fig. 3). After 
HST, all animals responded to 100% of the GHRF injections during the 
control period, mean GH (5-20 min after injection of saline) was 5 +/-
0.3 ng/ml, which was less than 55 +/- 16 ng/ml (P<0,04) during the 
0.067-*ug GHRF period (5^20 min after GHRF). The mean of the control 
period during the 0.133-ug GHRF trial was 4 +/- 0.4 ng/ml, which 
contrasts with the GHRF period mean of 33 +/- 11 ng/ml (P<0.06). The GH 
response between the two GHRF doses was not statistically different. 
i;'ig. 2. Photomicrograpdis of adenohypof^ysis of four hypothalamic-stalk 
transected (HST) (a, b, c, and d) and two shanHoperated 
controls (SOC) (e and f) calves. Histological cross sections 
are from the middle one third of the anteromedial part of the 
adenohypophysis. Acidophils with cytoplasm were dispersed in 
anteromedial regions of the adenohypophysis in both groups of 
HST and SOC calves. AcidogAils are associated with 
somatotrogAis, lactotrogAis and adra^ocort icotrophs. 
Chromophobes were evident throughout the adenohypc^ysis in HST 
and SOC calves. Histological sections indicate survival of 
adenohypophysial cells in HST calves (x 360) 
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TRH Response (Exp. 2) 
GH secretion in response to TRH was variable in HST calves. Only 
two of the five HST calves responded to TRH injections by an increase in 
GH similar to that evoked by hpGHRF which accounts for the increaed 
variability in the GH peak as seen in Fig. 4. Although only 40% of them 
responded to a TRH challenge, all HST calves released GH in subsequent 
treatments with hpGHRF and rhGHRF. 
Multiple Injections of GHRF (Exp. 3) 
Eight days after surgery, all HST calves responded to the two 
injections of hpGHEŒ* (Pig. 5). Plasma concentrations of GH were the 
same before each injection of hpGHRF (3.7 and 3.6 ng/ml) and signif­
icantly lower than after hpGHRF (P<0.05). The second injection of 
hpGHRF, which occurred after feeding, did not increase plasma GH to the 
same extent as the first injection (9 vs 17 ng/ml, P<0.09). 
SRIH and GHRF on GH Secretion (Exp. 4) 
Infusion of 0.033 and 0.067 ug SRIH/kg bwt*min depressed GH release 
when a bolus of 0.067 ug hpGHRF/kg bwt was administered (Fig. 6). GH 
levels 20 min after GHRF were 9 +/- 1.6 ng/ml during infusion of 0.033 
ug SRIH and 5 +/- 0.4 ng/ml during infusion of 0.067 ug SRIH. The 
changes in plasma GH during the infusion of either dose of SRIH were not 
significantly different in any part of the experiment or between doses 
of SRIH. After the infusion of SRIH, GH concentrations ranained stable. 
fig. 3. Plasma GH concentrations in hypothalamic-stalk (HST) calves in 
response to 0, 0.067 and 0.133 ug (1-40)-(M %)GHRF/kg bwt are 
illustrated by the closed triangles (A), (n=5), For 
conqparison, the response to 0.067 and 0.10 ug (1^40)-OH 
hpGHRF/kg bwt before surgery in these animals is indicated by 
the open circles (o) in the left and right panels, 
respectively. The GH response to 0.067 ug hpGHRF is shown in 
the left panelf and the right panel indicates the effect of tiie 
more concentrated dose of t^sGHRF. Arrows indicate the time of 
vehicle or GHRF administration. Values are the mean +/- SE 
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rhGHRF Dose Response (Exp. 5) 
Plasma GH was stimulated in a âose^dependent manner to two analogs 
of rhGHRF in HST and SOC calves (Tables 1 and 2). All animals responded 
to either analog of rhŒRF when the dosage was 0.0165 ug rhGHRF/kg bwt 
or greater. No differences in plasma GH response between HST and SOC 
calves were observed. 
Fig. 5. Plasma GH in hypothalamic-stalk transected (HST) calves 
receiving 0.067 ug hpGHRF/kg bwt at 3^hr intervals for 6 hr are 
indicated by the closed triangles (A), (n=5). The response to 
the same treatment before HST is shown by the opai circles (o). 
The time of feeding and hpGHRF injections are illustrated by 
arrows. Values are the mean +/•* SE 
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transected (HST) calves during iv infusion of 0.033 and 0.067 
ug somatostatin(SS)-14 (SRIH)/(kg bwt*min) and injected with 
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triangles (A), (n-2). Hie same animals' response to these 
hormone treatments before surgical intervention is shown by the 
<^n circles (o). Arrows indicate the time of QIRF injections # 
and the hatched areas illustrate the period of SRIH infusion 
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Table 1. Effects of rat hypothalamic CHRP, [Nle^^] rhGHRP(l-29)-NH2/ on 
plasma GH levels in HST and SOC calves 5 mo after surgery 
Plasma GH concentration® 
Dose of [Nle^']rhGHRP(l-29)NHo nq/ml 
given iv (ugAg bwt) WST calves sod calves 
0.0000^ 3.0 +/- 0.6 5.6 +/: 1.2 
0.0083 6.7 +/- 2.1 9.4 +A 0.9 
0.0165 12.2 +/- 3.7 10.9 +/- 3.4 
0.033 12.8 +/- 5.4 14.7 +A 2.0 
0.067 16.5 +/- 5.8 14.4 +/- 5.6 
0.133 24.6 +/- 7.4 8.5 +/- 1.8 
^Values are means +/- SE. 
'Vehicle consisting of 0.01 M NaH^po.^HgO, 0.01% ascorbic acid and 
1% bovine serum albumin. 
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Table 2. Effects of rat hypothalamic CHRP, rhGHRP(l-32)-OH, on plasma 
GH levels in HST and SOC calves 6 mo after surgery 
Plasma GH concentration® 
Dose of rhGHRF(l-32)-OH nq/ml 
given iv (ug/kg bwt) HST calves SOC calves 
0.0000^ 1.7 +/- 0.2 2.1 +/- 0.2 
0.0083 3.1 +/- 0.8 3.2 +/: 0.8 
0.0165 3.4 +/: 0.5 4.2 +/- 0.6 
0.033 5.9 +/- 1.9 7.3 +/- 1.5 
0.067 7.4 +/- 2.9 19.0 +/- 6.5 
0.133 17.4 +A 9.9 26.0 +A 3.6 
^Values are means +/- SE. 
Vehicle consisting of 0.01 M NaH2PO.*H20, 0.01% ascorbic acid and 
1% bovine serum albumin. 
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DISCUSSION 
Plasma GH concentrations were acutely altered by the surgical 
procedures of HST and SOC in prepubertal calves. When the anesthesia 
was administered f GH increased abruptly for 60 min. After the 
anesthesia was discontinued, GH remained elevated in the SOC calves, 
whereas it dropped to basal levels in HST calves. The return of 
episodic GH secretion in SOC calves and its absence as well as depressed 
GH release in HST calves are similar to results reported by Anderson et 
al. (1, 15). In contrast, basal GH secretion in HST pigs remains 
greater than that in SOC animals (2, 16). Although plasma prolactin 
levels were not altered by anesthesia in these calves, HST caused 
consistently greater prolactin secretion compared with that in SOC 
animals (17-18). 
The pattern of abrupt GH release in response to GHRF in HST calves 
was similar to that seen before surgery as well as in SOC animals. The 
high amplitude of the GH response to the first injection of hpGHRF at 3 
days after surgery could not be replicated by later challenges. There 
was a dose dependency to rhGHRP in HST calves several months after 
surgery, which is similar to the GH response to hpGHRF or rhGHRF seen in 
HST pigs (16). Furthermore, both analogs of rat hypothalamic GHRF were 
effective in causing GH release in HST as well as SOC calves. 
The pituitary in HST calves was capable of releasing GH in response 
to TRH, but only 40% of the animals responded to the TRH injections, 
whereas 100% of them responded to hpGHRF and rhGHRF. This variable 
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response to exogenous TRH has also been observed in intact cattle (19). 
Szabo (20) demonstrated that GHRF and TRH act through different 
mechanisms in the pituitary to release GH. The release of GH by GHRF is 
cAMP- and Ca^'^'-mediatedf Whereas TRH mediates GH release by a 
cAMP-independent, Ca^'^'-dependent process. The different mechanisms for 
mediation of GH release by the peptides may account for the variation in 
the ability to respond to the stimuli. 
When HST calves were subjected to GHRF at 3^hr intervals, they 
responded to the first hormone injection with greater GH release than to 
the second GHRF injection, which occurred after feeding. The depression 
in GH response to the same dose of GHRF after 3 hr may be related to 
effects of feeding, nuitiber of GH-release challenges since surgery, or 
down regulation of the pituitary. These results are similar to the 
animals response before surgical manipulation, however, the magnitude of 
the GH response to 0.067 ug GHRF before and after feeding was enhanced 
by surgery. 
During SRIH infusion, GHRF did not significantly increase GH 
release in HST calves. After SRIH infusion, plasma GH was not altered. 
This contrasts with intact calves in which a somatotropic rebound was 
observed after SRIH withdrawal (21-24). Because the pituitary was no 
longer under exogenous SRIH and GHRF regulation after HST, it may not 
need to compensate for the GH-release suppression during SRIH infusion 
periods in these calves. For example, when these same treatment 
regimens of GHRF and SRIH were conducted before surgical manipulation, 
the variation of GH secretion was much greater than after HST. The mean 
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of all experimental coefficients of variation before surgery was 61%^ 
whereas after HST, it was reduced to 17% (P<0.001). The reduced 
variation of GH secretion after HST may be explained by the lack of 
episodic secretion of GH that has been observed previously in HST 
animals (1, 2). 
In conclusion, this is the first demonstration of a GH response to 
hpGHRF and rhGHRP injections in HST calves. Without the hypophysial 
stalk connection, the calves always responded to GHRP challenges. After 
HST, the pituitary remains capable of responding to other exogenous 
substances such as TRH, as well as of secreting greater amounts of 
prolactin than found in SOC calves. Finally, the somatotropic rebound 
observed in intact calves after SRIH withdrawal is not observed after 
HST. After HST, the pituitary was able to respond to a variety of 
stimuli; however, desensitization of the pituitary may occui; during the 
period immediately after surgery, but the calves remain responsive to 
GHRF challenges several months later. 
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SECTION IV. GROWTH HORMONE (GH) PROFILES, 
METABOLIC CLEARANCE RATES, 
SECRETION RATES, HALF-LIFE, AND 
GH RESPONSE TO GH-^RELEASING 
FACTOR AT FOUR AGES IN INTACT AND 
CASTRATE MALE AND FEMALE CATTLE 
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ABSTRACT 
Growth hormone (GH) parameters were examined in intact and 
castrated male and female cattle (4 of each), at 5, 8^ 12, and 15 mo 
(+/- 2 wks) of age. Plasma GH profiles, secretion rates (SR), metabolic 
clearance rates (MCR), half-life of intravenously infused GH, and GH 
response to 0.0165, 0.067 and 0.267 ug of growth hormone-releasing 
factor (GHRF)Ag body weight (bwt) were studied. As cattle aged, 
overall GH levels in the plasma decreased, GH baseline declined, the 
frequency and amplitude of GH spikes and secretory periods diminished 
(P<0.05), SR decreased (P<0.001), half-life of infused GH decreased 
(P<0.01), and the GH response to intravenous (iv) injections of GHRF 
declined (P<0.05). Bulls had an elevated overall GH mean and GH 
baseline concentration, greater anplitude of GH spikes and a greater 
number of secretory periods (P<0.01), faster SR (P<0.05), and a greater 
GH response to 0.267 ug GHRF/kg bwt than steers, heifers, or 
ovariectomized heifers. Males had more frequent GH spikes and secretory 
periods of higher amplitude, greater SR, and greater GH responses to 
0.0165 ug GHRFAg bwt (P<0.05) than females. Heifers had a lower MCR 
than ovariectomized heifers (P<0.05). Intact and castrated cattle did 
not differ in GH parameters. These results suggested that testosterone 
and its metabolites enhanced GH secretion, and decreasing GH 
concentrations were associated with increasing age. 
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INTRœUCTION 
There are many factors known to affect growth hormone (GH) 
concentrations in ruminants, such as nutrition, breed, age, sex, and 
castration (1-7). GH in ruminants is secreted over time as peaks 
occurring at random (2, 8«^9). Due to this random secretion, GH has been 
difficult to define without serial sampling in ruminants. 
Characterization of Œ profiles in ruminants has been attempted by 
defining the overall concentration of GH, GH baseline, and number and 
anplitude of GH secretory periods. However, these studies have only 
examined intact and castrate males or ovariectomized ewes (2, 8-9). In 
the rat, the pattern of GH secretion has been considered to be related 
to the differences in growth rates between males and females (10). In 
order to determine if differences in growth rates between intact and 
castrate male and female cattle are related to differences in GH 
secretory patterns, a characterization of their GH profiles is required. 
The concentration of GH in blood is generally the result of the 
balance of secretion rate (SR) and metabolic clearance rate (MCR). 
Although SR and MCR comparisons have been conducted in males and females 
at different ages, they have not been studied in conjunction with GH 
profiles (11). 
The purpose of this study, therefore, was to evaluate the GH status 
in growing male and female cattle, both intact and castrated, over a 
range of 10 months. This was accomplished by measuring GH concentration 
in the plasma at 20-min intervals over a 12-hr period and then 
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characterizing the profiles, determining MCR, SR and half-life of GH, 
and examining the GH response to 3 doses of exogenous GH-'releasing 
factor (GHRF). 
110 
MATERIALS AND METHODS 
Animals 
Sixteen crossbred cattle (8 male and 8 female) were studied at 5, 
8, 12f and 15 mo of age. Four male and 4 female animals were castrated 
at 6 months. The calves remained with their dams on pasture until 6 mo 
of age. The animals were then placed in a sheltered feedlot and fed a 
diet of 49% cracked corn, 30% ground cob, 10% molasses, 10% solvent 
extracted soybean meal, and 1% salt, minerals, and vitamin A. At 10 
mos, the cattle were individually fed the diet using electronic 
broadbent headgates (American Calan Inc., Northwood, NH) to allow 
unrestricted feed intake. Two indwelling catheters (Tygon microbore 
tubing, 1.27 mm i.d.. Fisher Scientific, Pittsburgh, PA) were inserted 
into each jugular vein at least 1 day before experiments began. Patency 
of catheters was maintained overnight with sterile physiological saline 
containing 100 U heparin/ml, and sterile saline containing 20 U 
heparin/ml between sampling. One catheter was used for infusion, and 
another for blood samples. Blood samples were treated with heparin (4 
U/ml) and plasma stored at -IS'C until analyzed for GH (12). The GH 
assay had intra- and inter-assay coefficients of variation of 1.8% and 
13.8%, respectively. 
Peptides 
(3i was purified using the methods of Dellacha and Sonnenberg (13), 
Wallis and Dixon (14) and Lorenson and Ellis (15) as modified by J. L. 
Bobbitt (Eli Lilly Inc., Indianapolis, IN; personal communication). The 
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purified GH paralleled the GH standard in the GH radioiimunoassay and 
was 4% less reactive than the GH standard. Purified GH was dissolved in 
a sodium bicarbonate buffer, pH 11.0 (4.24 g NagCO^; 7.45 g KCl; 3.0 ml 
1-N HCl; to 500 ml with HgO) for infusion. [Nle^^] (1-29)-NHg rat 
hypothalamic (rh) GHRF (16) was dissolved in 0.1% acetic acid (1 ug/ul) 
before making to volume in sterile buffer, pH 7.0. The buffer was 
physiological saline (0.818% NaCl) containing 0.01 M NaH2P0^*H20, 0.01% 
ascorbic acid and 1% bovine serum albumin. Peptide solutions were 
prepared the day of experimentation. 
Experiments 
On the first day of experimentation, 10-'ral blood samples were drawn 
at 20-min intervals for 12 hr to determine the pattern of GH release. 
Immediately following the 12-ihr profile, a dose of 0.0165 or 0.067 ug 
rhGHRF/kg bwt was administered to the animals. Blood samples were taken 
1, 10 and 20 min before the bolus injection of GHRF and 5, 10, 15, 20, 
40, and 60 min after injection. On day 2, administration of 0.0165 or 
0.067 ug GHRF/kg bwt was administered to the cattle and blood sampled as 
described for day 1. One to two hr later, a calculated concentration of 
Œ was infused to attain a steady concentration of 40 ng/nnl (12), and 
averaged 47.4 ng/ml when the plasma was verified later by 
radioiimunoassay. GH was infused at a rate of 0.37 ml/min using 
peristaltic pumps (Harvard, Model 1505, Harvard Apparatus, Millis, NJ) 
to determine MCR, SR and half-^life of GH. Samples were taken 1 min 
before infusion, 10, 20, 30, 70, 80, and 90 min during infusion, and 5, 
10, 15, 20, 25, 30, 40, and 50 min after the infusion. Eight of the 
112 
cattle received 0.2667 ug rhGHRF/kg bwt after a 5-hr rest period. The 
blood sanpling was similar to the GHRF administration described 
previouslyf with the exception that blood was sampled an additional 60 
min at 20-min intervals. At 8, 12 and 15 mo of age, animals were fed 5 
hr after the start of the experiment on both days. 
The calculations to determine the MCR, SR and half^life of GH were 
similar to those described by Trenkle (11) with the SR calculated from 
the MCR and the average baseline GH concentrations during the control 
infusion period. The MCR and SR were adjusted to kg bwt basis for 
statistical analysis to compare the animals at different ages. 
Statistics 
The 12^hr GH profile analysis was based on Christian et al. (17) 
skewness coefficients as adapted to SAS procedures (18) with several 
additional modifications (Appendix). Spearman correlation coefficients 
as described by SAS (18) were used to determine if the GH concentrations 
were changing with time the animals were sorted by linear, quadratic or 
no correlation based on the Spearman correlation coefficients of the GH 
profiles. After adjusting for the trends, autocorrelations with a lag 
of one on the residuals were run to determine spike locations. The 15 
maximum points were tested as outliers using the skewness test and the 
univariate procedure. If the autoregression residual value was equal or 
greater than 1.0, then the corresponding GH value was considered a 
spike. If the GH concentration returned to baseline or below for 1 or 
more samples, the spikes surrounded by the baseline samples were 
considered to be a period of secretion. The hormone concentration at an 
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identified spike was the anplitude for the hormone spike. The average 
of the GH concentration of the identified spikes within a secretory 
period was considered to be the amplitude of a period of secretion. The 
overall mean was the average of all GH samples taken in the profile. 
The baseline mean was determined by removing the samples identified as 
spikes from the average. 
After different segments of the GH profile were identified, they 
were included in a SAS analysis with the other GH data in the 
experiments for the split-plot analysis (19) using the general linear 
model procedure (18). 
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RESULTS 
Overall mean GH, baseline, number of spikes, spike an^litude, and 
secretory period amplitude significantly declined as the cattle aged 
(Figs. 1-^4, Table 1). Baseline GH declined between 5 and 15 mo 
(P<0.009). An average decrease of two GH spikes in a 12^hr period 
occurred between 5 and 15 mo in the cattle (P<0.004). There were fewer 
spikes of GH at 15 mo as well as 27% less amplitude of the spikes than 
at 5 mo (P<0.04). Although the number of periods of GH secretion was 
not changed as the animal aged, the average amplitude of the secretory 
periods declined between 5 and 15 mo (P<0.04). 
Bulls had different plasma GH profiles than steers, heifers or 
ovariectomized heifers (Figs. 1-4; Table 2). Considerable variation 
between animals was observed (Figs. 1-^4). The overall mean of GH in the 
bulls was greater than the other animals (P<0.02). Even by the removal 
of the spikes of GH secretion from the overall mean, the baseline 
concentration of GH in bulls was significantly greater than steers, 
heifers and ovariectomized heifers. Males had more spikes of GH as well 
as more periods of GH secretion than the females (P<0.02). Bulls had a 
greater mean amplitude of the secretory periods and GH spikes (P<0.01) 
compared with steers, heifers or ovariectomized heifers. 
A statistical interaction between males and females at different 
ages occurred with the number of spikes in a 12-hr period (P<0.05). In 
females, the number of GH spikes decreased with age (5.5, 3.5, 3.3, and 
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2.5 at 5, 8, 1 2 f  and 15 mo, respectively); while the number of GH spikes 
in males was 5.5, 4.4, 5.1, and 4.5, respectively, for the same periods. 
The M2R and SR of GH are summarized in Table 3 for the four groups. 
MCR was significantly less in intact heifers than other animals 
(P<0.02). Bulls, steers and ovariectomized heifers had similar MCR. 
Bulls had a greater SR of GH than the other animals (P<0.03). Males had 
higher SR than females (P<0.0001). The half-life of GH was not 
different between intact and castrated male and female cattle. 
MCR and SR according to age of cattle are summarized in Table 4). 
MCR significantly increased at 8 mo (P<0.02) but declined to levels 
similar to 5 mo at 12 and 15 mo. Secretion of GH was greater at 5 and 8 
mo than 12 and 15 mo (P<0.0006). The half^life of GH declined 
(P<0.0001) between 5 and 8 mo and remained unchanged thereafter. 
Fig. 1. Profiles of plasma Qi over 12 hr in bulls at 5, 8, 12, and 15 
mo of age. Each panel illustrates GH concentrations for each 
animal. Individuals have the same symbol in each panel 
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Profiles of plasma GH over 12 hr in steers at 5, 8, 12, and 15 
mo of age. Eadi panel illustrates Oi concentrations for each 
animal. Individuals have the same symbol in each panel 
12 mo 
Minutes 
Fig. 3. Profiles of plasma GH over 12 hr in heifers at 5, 8, 12, and 15 
mo of age. Eadi panel illustrates Qi concentrations for each ' 
animal. Individuals have the same symbol in each panel 
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Profiles of plasma GH over 12 hr in ovariectomized heifers at 
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Table 1. Plasma growth hormone profiles in cattle at different ages^ 
Parameter Age 
5 mo 8 mo 12 mo 15 mo SE 
Overall GH concentration, 
ng/ml" 5.1 4.4 3.7 3.1 0.3 
GH baseline, 
ng/ml° 3.9 3.3 2.8 2.4 0.3 
Number of GH 
secretory periods 2.7 2.9 3.0 „ 2.4 0.4 
Mean amplitude of GH 
secretory periods, 
ng/ml° 9.2 9.9 6.8 6.4 0.9 
Number of GH spikes® 5.5 3.9 4.2 3.5 0.3 
Mean amplitude of Œ 
spikes, ng/ml^ 8.1 9.1 6.4 5.9 0.7 
^Average of all animals (bulls, steers, heifers, and ovariectomized 
heifers) over 12 hr. 
^Overall GH concentrations at 5 mo is different from 12 and 15 mo 
(P<0.006) and 8 mo is different from 15 mo (P<0.009), 
^Baseline GH at 5 mo is different from 12 and 15 mo (P<0.009) and 8 
mo is different from 15 mo (P<0.03). 
'^an amplitude of GH secretory periods at 8 mo is different from 
12 and 15 mo (P<0.02) and 5 mo is different from 15 mo (P<0,04). 
^Number of GH spikes at 5 mo is greater than at 8, 12 or 15 mo 
(P<0.004). 
f 
Mean amplitude of GH spikes at 5 and 8 mo are greater than at 15 
mo (P<0.04) and 8 mo is greater than 12 mo (P<0.02). 
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Table 2. Plasma growth hormone profiles in intact and castrated males 
and females® 
Parameter Bulls Steers Heifers 
Ovariec-
tomized 
Heifers SE 
Overall GH concentration, 
ng/ml° 5.3 4.2 3.2 3.4 0.3 
GH baseline, 
ng/ml^ 3.9 3.1 2.5 2.7 0.3 
Number of GH 
secretory periods" 3.2 3.0 2.1 2.6 0.3 
Mean amplitude of Œ 
secretory periods, 
ng/ml® 11.4 8.0 6.8 6.1 0.9 
Number of GH spikes^ 4.9 4.9 3.5 3.9 0.3 
Mean amplitude of GH 
spikes, ng/ml^ 10.1 7.4 6.3 5.8 0.7 
^Average of 12-hr periods at 5, 8, 12, and 15 mo of age. 
'^Overall GH concentration of bulls is different from all others at 
(P<0.02) and steers are different from heifers (P<0.05). 
^GH baseline in bulls is different from others (P<0.03). 
^Heifers have fewer secretory periods than bulls and steers 
(P<0.02). 
^ean amplitude of GH secretory periods of bulls is different from 
all others (P<0.01), 
^Number of GH spikes of males is greater than fanales (P<0.02). 
^Mean amplitude of GH spikes of bulls is greater than others 
(P<0.01). 
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Table 3. Metabolic clearance rate, secretion rate and half-life of 
growth hormone in intact and castrated males and females 
Item Bulls Steers Heifers 
Ovariec­
tomized 
Heifers SE 
Metabolic clear 
ance rate, 
liter/(hr*kg)B 0.143 0.140 0.132 0.149 0. 005 
Secretion rate, 
ug/(hr*kg)G 0.791 0.640 0.450 0.513 0. 046 
Half-life, min 15.0 15.8 15.5 15.0 0. 7 
Average body 
weight, kg® 319 278 303 268 3 
^Heifers are different from ovariectomized heifers (P<0.02). 
^Bulls are different from all other animals (P<0.03). Heifers are 
different from steers (P<0.01). 
°A11 groups are different from each other (P<0,02). 
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Table 4. Metabolic clearance rate, secretion rate and half-life of 
growth hormone in cattle at different ages 
Item 5 mo 8 mo 12 mo 15 mo SE 
Metabolic clearance 
rate, 
liter/(hr*kg)3 0.130 0.159 0.134 0.141 0.005 
Secretion rate, 
ug/(hr*kg)® 0.695 0.737 0.506 0.456 0.046 
Half-life, min° 17.7 14.8 14.5 14.2 0.7 
Body weight, kg<^ 139 222 367 440 3 
^Metabolic clearance rate at 8 mo is greater than 5, 12 and 15 mo 
(P<0.02). 
^Secretion rate at 5 and 8 mo is greater than 12 and 15 mo 
(P<0.0006). 
^Half-life at 5 mo is faster than 8, 12 and 15 mo (P<0.008). 
^All ages are different from each other (P<0.0001). 
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Response to injections of rhGHRF as the animals aged is listed in 
Table 5. The mean concentrations of GH before injections (20, 10 and 1 
min; preGHRF) of 0.0165, 0.067 and 0.267 ug rhGHRF/kg bwt declined from 
concentrations above 5.0 ng/nnl at 5 mo to concentrations between 2.0^3.0 
ng/ml at 15 mo (P<0.02). The response (calculated from the average of 
5, 10, 15, and 20 min samples after injection) to 0.0165 ug GHRF/kg bwt 
was greater at 5 mo than at 8 mo (P<0.01). However, the response at 5 
mo was not different from the responses at 12 and 15 mo. At 5 mo, the 
GH response to 0.067 ug GHRF/kg bwt was greater than the responses at 8, 
12 and 15 mo (P<0.01). A similar level of response was observed when 
0.267 ug GHRF/kg bwt was administered at 5 mo. This level was also 
greater than the responses at 8, 12 or 15 mo (P<0.04). 
GH response to rhGHRF in castrated and intact male and female 
cattle is summarized in Table 6. The bulls had a greater preGHRF 
concentration at the 0.0165-ug GHRF dose than females and a greater 
response to the dose than females (P<0.02). However, when these values 
were converted to a percentage change basis from the preGHRF period to 
the GHRF response period, there was no difference among bulls; the 
percentage increase among steers, 24%, heifers 52%; and ovariectomized 
heifers, 16%. The percentage change in GH concentration from the 
preGHRF to the 0.^067-ug GHRF response was 142% in bulls, 78% in steers, 
163% in heifers, and 139% in ovariectomized heifers. Bulls had a 
greater response to 0.267 ug GHRF/kg bwt than intact or ovariectomized 
heifers (P<0.02). The percent increase from 0.267 preGHRF to 0.267 GHRF 
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response in bulls, however, was 198%, and was not different from intact 
(146%) and ovariectomized (204%) heifers. 
Over both sexes, castration did not have an effect on GH profiles, 
metabolic parameters or GH response to CHRP. When comparing intacts and 
castrates of the same sex, castrate males had lower GH baseline, GH 
amplitude of secretory periods and spikes, and GH SR/kg bwt than intact 
males, and ovariectomized heifers had higher MCR/kg bwt than intact 
heifers. 
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Table 5. Response to growth hormone-releasing factor in cattle of 
different ages 
Age 
Dose Period 5 mo 8 mo ' 12 mo 15 mo SB 
0.0165 PreGHRF®'^ 5.8 
GH 
3.6 
(nq/ml) 
4.5 2.9 0.6 
GHRF°»^ 6.1 3.9 5.1 4.7 0.6 
0.067 PreOTRF®'® 5.1 4.4 4.5 2.7 0.7 
GHRpC'f 14.3 6.5 9.2 8.0 1.4 
0.267 PreGHRP®»® 5.2 3.6 3.0 2.3 0.8 
GHRF°»9 14.2 9.7 7.8 5.8 1.4 
^Mean of 20, 10 and 1 min before CHRP injection. 
^GH at 5 mo is different from 8 and 15 mo (P<0,02). 
°Mean of 5, 10, 15, and 20 min after GHïîF injection. 
^Plasma GH response at 5 mo is different from 8 mo (P<0.01). 
®Plasma GH at 5 mo is different from 15 mo (P<0.02). 
^Plasma GH response at 5 mo is different from 8, 12 and 15 mo 
(P<0.01). 
^Plasma GH response at 5 mo is different from 8, 12 and 15 mo 
(P<0.04). 
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Table 6. Response to growth hormone-releasing factor in castrated and 
intact male and female cattle 
Ovariec-» 
tomized 
Dose Period Bulls Steers Heifers . Heifers SE 
GH (nq/ml) 
0.0165 PreGHRF®'^ 5.9 4.2 2.9 3.8 0.6 
GHRpC'd 5.9 5.2 4.4 4.4 0.6 
0.067 PreGHRF®'® 4.3 5.4 4.0 3.1 0.7 
GHRpC 10.4 9.6 10.5 7.4 1.4 
0.267 PreGHRF®'^ 4.5 4.2 2.8 2.6 0.8 
GHRF^'°'^ 13.4 9.5 6.9 7.9 1.4 
^ean of 20, 10 and 1 min before CHRP injection. 
^Bulls are different from heifers and ovariectomized heifers 
(P<0.02). 
'^Mean of 5, 10, 15, and 20 min after GHRF injection. 
banales are different from males (P<0.03). 
^Steers and ovariectomized heifers are different (P<0.04). 
^Only two animals per group. 
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DISCUSSION 
The data presented here are part of a more extensive study of 
growing male and female cattle, both intact and castrated, in which the 
GH status as well as steroid and metabolic hormones and changes in body 
composition were examined as the cattle aged. The overall purpose of 
these studies was to define endocrine relationships related to growth as 
influenced by sex, castration and age. 
Plasma levels of GH were quite low in the present study which may 
have been related to the nutritional regime. Breier et al. (5) reported 
that at high levels of feeding, GH peaks were of low amplitude and short 
duration in cattle, whereas, at medium and low planes of nutrition, Qf 
peaks were high with multiple-phasic release and slow decay. Thus, the 
low amplitude of the few GH secretory periods in this study may have 
resulted from feeding cattle the high energy diet at a high level of 
intake. 
The different diet that the animals received at 5 mo and the rest 
of the experiment may have caused differences in the MCR and half^life 
of GH which occurred during those periods. At 5 mo, the calves were 
nursing their dams. When being sampled at 5 mo, the calves did not 
have access to their dams and may be considered to have been fasting. 
At 8, 12 and 15 mo, the cattle had access to their diet during the 
experiment and were, therefore, in a fed state. Trenkle reported that 
fasting ruminants had longer GH half"life and lower MCR (12). 
Therefore, differences in MCR and half-life of GH between 5 mo and 8, 12 
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and 15 mo may not have been age related, but may have been due to 
nutritional intake differences. 
With aging, overall GH concentration in plasma significantly 
declined in cattle. This was a result of a decline in baseline GH, 
number of spikes of GH, amplitude of GH spikes, and decreased SR on a kg 
bwt basis. The decrease of GH with age has been observed previously in 
cattle (20-21). The decline in SR/kg bwt has also been observed in 
cattle (21) and pigs (22), and may be the result of less pituitary 
tissue per unit of body weight with increase in body size. 
The declining number and amplitude of GH spikes and secretory 
periods with increasing age may have been caused by decreased pituitary 
responsiveness to GHRF or less pituitary per unit of body weight. The 
GH response to all doses of GHRF was greater at 5 mo than 8, 12 or 15 
mo. This was similar to the results of another study with sheep in 
v\Aiich basal GH and GH response to GHRF decreased with age (23). In 
humans, the GH response to GHRF was shown to peak between 20-30 years 
and then decline after 40 years of age (24). On the other hand, the 
differences in GH response to GHRF between 5 mo and 8, 12 and 15 mo, may 
have been related to nutrition. Because the calves at 5 mo could be 
considered fasting, they may have responded in a similar manner to sheep 
on a restricted plane of nutrition injected with GHRF in which the GH 
pulses were more persistent than sheep with free access to food (25). 
Whereas steers and intact and ovariectomized heifers gradually lost 
their episodic secretion of GH during aging, bulls maintained secretory 
periods of high amplitude at 15 mo. Intact male cattle have been 
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reported to maintain periodicity of GH secretion at 2, 3 and 5 years 
(1). This may be due to high androgen concentrations in bulls, because 
androgens have been related to increased amplitude of GH (26), increased 
overall GH secretion {2, 27), enhanced response of pituitary to other 
stimuli (27), and increased GH content of the pituitary (28). Bulls had 
a higher concentration of total estrogens in their plasma than the other 
groups (29) which may have been caused by aromatization of testosterone 
in bulls (30). High concentrations of endogenous estrogens may have 
stimulated GH secretion similar to exogenous estrogen administration. 
Exogenous estrogens in ruminants have been shown to enhance GH secretion 
by an increased frequency of GH secretory periods (4), and Trenkle (31) 
concluded that in cattle, estrogen increased pituitary size, GH content 
of the pituitary per unit bwt and Qi in the plasma. 
The difference in GH secretory patterns between bulls and steers 
was in agreement with other studies (2, 9). Males had more periods of 
secretion and spikes of GH than females. Bulls had a faster SR without 
an increase in MCR while intact heifers had a faster MCR with a 
decreased SR. The faster MCR and lower levels of GH of heifers were 
similar to results reported by Trenkle (11). Trenkle (32) also noted 
that changes in plasma hormone concentration were affected more by SR 
than MCR. 
The response of GH to GHRF is unclear, some studies detected no 
differences in the GH response in humans between males and females, 
vAiereas others have shown that high doses of GHRF caused males to have a 
greater GH response than females (33^34). The sex differences observed 
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in this experiment were dependent upon the dose of GHRF administered: 
with the low dose, males responded with more GH release to GHRF 
administration than females; with the medium dose, no difference in the 
GH response was observed; and with the high dose, bulls secreted more GH 
than the other animals. Greater GH response to GHRF has been seen in 
ea-day^old male rats compared with female rats (35), but this sex 
difference in GH response was absent in 30-day*old rats. When 
testosterone treatment was given to intact and gonadectomized 60<day-old 
male rats, the GH response to GHRF again increased (35). Evans et al. 
(36) demonstrated in vitro that testosterone but not estradiol, enhanced 
the GHRF^mediated GH release by perifused male rat pituitary cells. 
Webb et al. (37), noted that estrogens did not affect basal GH or GHRF 
response but increased net synthesis of GH in the pituitary without 
affecting GH release. It has been suggested that estrogens play a minor 
role in the modulation of GH response to GHRF, whereas testosterone may 
increase pituitary cell content and enhance the GH response to GHRF in 
males (35-36). Hoeffler and Frawley (38) observed that the sex 
differences of GH release was due to differences in the secretory 
capacity of individual somatotropes rather than differences in the 
number of GH cells in the pituitary of rats. 
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ABSTRACT 
The influence of age, sex and castration on plasma concentrations 
of metabolic hormones related to growth were examined in beef cattle. 
Plasma was sampled from four bulls, four steers, four heifers, and four 
ovariectomized heifers at 20Amin intervals for 12 hr at 5, 8, 12, and 15 
mo of age. Plasma was composited for analysis of somatomedin-C (Sm-C), 
testosterone, total estrogens, thyroxine, triiodothyronine, insulin, and 
glucose. Sm-'C increased in the plasma front 5 to 12 mo of age 
(P<0,0001). Bulls had greater levels of Sm-C than steers, heifers or 
ovariectomized heifers (P<0.0001). In bulls, testosterone increased 
from 0.2 ng/ml at 5 mo to 5.6 ng/ml at 15 mo (P<0.0002). Total 
estrogens were highest in bulls (P<0.002), and were elevated in all 
animals during the summer months whai they were 5 and 15 mo of age 
(P<0.0005). Triiodothyronine concentration was greater in 
ovariectomized heifers than bulls (P<0.004) or steers (P<0.04). 
Triiodothyronine was also increased at 8 and 12 mo (P<0.0001), vAiich 
coincided with winter and early spring. Females had higher 
concentrations of thyroxine than males (P<0.002). At 5 mo, the 
thyroxine level was less than at any other age (P<0.001). Insulin and 
glucose levels were not influenced by sex, castration or time of 
feeding. Insulin increased with age (P<0.001), whereas plasma glucose 
was elevated at 8 and 12 mo of age (P<0.004). Age or sexual maturation 
influenced the levels of metabolic hormones. High concentrations of 
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testosterone and its metabolites were associated with greater 
concentrations of Sm-C and total estrogens. 
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INTRODUCTION 
Endocrine regulation of growth is a balance of complex interactions 
of several hormones and their receptors. Growth hormone (GH) and 
somatomedin (Sm-C) are often considered the principal hormones 
regulating growth. However, GH and Sm-C have limited influence on 
growth without interaction with thyroid hormones, insulin, estrogens, 
androgens, and glucocorticoids. Seme characterization of these 
endocrine relationships as cattle and sheep mature has been reported 
(1^8). However, these studies were limited to either one sex or did not 
compare intact and castrated animals (1-8). Furthermore, most of the 
studies examined only a few of the growth-*related hormones or sampled 
blood infrequently, so that the overall endocrine pattern associated 
with growth was lost (1^5). 
The purpose of this study was to assess the influence of age, sex 
and castration on plasma concentrations of Sm-'C, testosterone, estrogen, 
thyroxine, triiodothyronine, and insulin in cattle. 
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MATERIALS AND METHODS 
The animals used in the study have been previously described (9). 
Briefly, bulls, steers, heifers, and ovariectomized heifers, four of 
each, were sampled for plaama hormone concentrations at 5, 8, 12, and 15 
mo of age. Blood samples were drawn via an indwelling jugular catheter 
every 20 min over 12 hr. Aliquots of the plasma were composited at 1-, 
4-* or 12-hr intervals. Sm-C was measured in the 12-hr composite using a 
double antibody radioimmunoassay (Immuno Nuclear Corp., Stillwater, MN) 
as modified by Plouzek and Trenkle (10). All sangles were assayed at 
one time and had an intraassay coefficient of variation (GOV) of 0.8%. 
Total estrogens were assayed using a double antibody radioimmunoassay 
(Radioassay Systems Laboratories, Inc., Carson, CA) on the 12-hr 
composite. The intraassay COV was.2.1%. Testosterone was measured in 
the 4-hr composites using a solid-phase radioimmunoassay that used 
antibodies covalently bound to the inner surface of plastic tubes 
(Immuno Nuclear Corp., Stillwater, MN) with an intraassay COV of 3.3%. 
Because the 3 composited sanples did not differ, the results of the 
testosterone assay were averaged for statistical analysis. The 4-hr 
composite of plasma was used for triiodothyronine and thyroxine analysis 
by solid-phase radioimmunoassay in which the antibodies were covalently 
bound to polymer particles (Amersham Corp., Arlington Heights, IL) and 
had intraassay COV of 3.7% and 4.1%, respectively. In all hormone 
assays, bovine plasma paralleled the assay standards. Plasma insulin 
(11) and glucose (Worthington Diagnostics, Inc., Freehold, NJ) were 
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analyzed using the hourly composites. Insulin had an interassay GOV of 
5.7% and an intraassay COV of 5.3%. The interassay and intraassay COVs 
for plasma glucose were 0.9% and 1.%, respectively. The results from 
the hourly analyses of insulin and glucose were averaged over 4-hr 
periods to evaluate levels before and after feeding. Animals were fed 
during the 5th hr of the IZ^hr sampling periods. A split^plot model 
(12) of the general linear model procedure of SAS (13) was used to 
analyze the endocrine data. 
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RESULTS 
Plasma Sm-C concentrations were significantly affected by sex and 
age of the animal (Table 1). Bulls had significantly higher 
concentrations of Sm-C than other animals (P<0.0001). The increase in 
Sm-C between 5 and 8 mo was greater in bulls than in other animals. 
This difference in bulls was maintained at 12 and 15 mo. Sm-C levels 
increased in all animals from 5 to 8 mo (P<0.0001) and from 8 to 12 mo 
(P<0.0001)f but did not change between 12 and 15 mo. Due to higher Sm-C 
concentrations in bulls, males had greater Sm^kz concentrations than 
females (P<0.0001), and intact animals had higher Sm-C concentrations 
than castrated cattle (P<0.0001). 
Bulls had measurable testosterone levels at 5 mo (Table 2), which 
increased at 8 mo (P<0.001) and 12 mo (P<0.0002). Testosterone 
concentrations in bulls leveled off between 12 and 15 mo. Steers, 
heifers and ovariectomized heifers only had trace concentrations of 
testosterone. 
Sex and castration affected plasma concentrations of total 
estrogens, triiodothyronine and thyroxine (Table 3). Over all ages, 
bulls had higher mean concentrations of total estrogens (P<0.02). Total 
estrogen concentrations were 9.6 and 7.9 pg/W. in males and females, 
respectively (P<0.0001), and 9.4 and 6.5 pg/tnl in intact and castrated 
animals, respectively (P<0.001). 
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Table 1. Somatomedin-C concentrations at different ages in intact and 
castratedr male and female, cattle 
Age Bulls® Steers Heifers 
Ovariec­
tomized 
Heifers SE 
mo nMol/liter 
5b 6.4 5.3 7.2 8.2 1.5 
8b 21.8 11.0 14.6 13.0 1.5 
12C 31.1 20.2 16.8 14.5 1.5 
15° 28.0 19.5 13.6 14.4 1.5 
^ean somatomedin-C concentration over the four ages of bulls (21.8 
nMol/liter) is greater than mean somatomedink: concentrations of steers, 
heifers and ovariectomized heifers (14.0, 13.0, and 12.5 nMol/liter, 
respectively, SE=0.8) (P<0.0001). 
^^an somatomedin-C concentrations over the four groups at 5 mo 
(6.8 nMol/liter) are less than 8 mo (15.1 nMol/liter) (P<0.0001). 
Slean scxnatomedin-C concentrations over the four groups at 12 and 
15 mo (20.6 and 18.9 nMol/liter, respectively) are similar to each other 
but different fran 5 mo (6.8 nMol/liter), (P<0.0001), and 8 mo (15.1 
nMol/liter), (P<0.0001). 
Triiodothyronine concentrations were highest in ovariectomized 
heifers (P<0.04), Castrated animals had greater triiodothyronine 
concentrations than intacts (P<0.04); and females had higher 
concentrations than males (P<0.0001). Thyroxine concentrations were not 
affected by castration but were significantly higher in fenales than 
males (P<0.002). 
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Table 2. Testosterone concentrations at different ages in intact and 
castratedf male and female, cattle 
Age BullsS Steers Heifers 
Ovariec-
tomized 
Heifers SE 
mo ng/ml 
5 0.15 0.01 0.03 0.01 0.29 
8 3.72 0.01 0.01 0.03 0.29 
12 5.45 0.01 0.01 0.01 0.29 
15 5.64 0.01 0.01 0.01 0.29 
Testosterone concentrations of bulls at 8, 12, and 15 mo are 
different than all other animals at all ages (P<0.001). Testosterone 
level at 8 mo in bulls differs from 12 and 15 mo (P<0.0002). 
The age of the animals or the season affected concentrations of 
total estrogens, triiodothyronine and thyroxine (Table 4). Total 
estrogens were higher at 5 and 15 mo which coincided with summer than at 
8 and 12 mo, the winter and spring months (P<0.0005). Triiodothyronine 
concentrations were higher at 8 and 12 mo and lower at 5 and 15 mo 
(P<0.0001). At 5 mo, thyroxine was 7.0 ug/dl, which was increased at 8, 
12 or 15 mo (P<0.0001). 
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Table 3. Total estrogens, triiodothyronine and thyroxine concentrations 
intact and castrated, male and female, cattle 
Hormone Bulls Steers Heifers 
Ovariec­
tomized 
Heifers SB 
Total estrogens. 
pg/ml® 11.9 7.2 8.5 7.3 0.7 
Tr i iodothyronine, 
ng/ml° 1.5 1.7 1.7 2.0 0.1 
Thyroxine, ug/dl^ 7.9 8.6 11.0 11.5 0.5 
^Concentrations of total estrogens of bulls are greater than other 
animals (P<0.002). 
^Triiodothyronine concentrations of ovariectomized heifers are 
greater than bulls (P<0.004) or steers (P<0.04), 
^Thyroxine concentrations of females are greater than males 
(P<0.002). 
Age, but not the sex of the animal, affected insulin and glucose 
concentrations (Table 5). Significantly lower levels of insulin were 
found at 5 mo than at 8, 12 or 15 mo (P<0.009). The difference at 5 mo 
may have been due to differences in diet, since the animals were still 
nursing at 5 mo of age. The insulin levels before and after feeding 
were not different. Plasma glucose concentrations were similar at 8 and 
12 mo, but higher than concentrations at 5 or 15 mo (P<0.04). Glucose 
concentrations dropped 0-4 hr after feeding and then returned at 4-'8 hr 
after feeding to levels similar to those before feeding. The 
glucose:insulin ratio steadily declined from 3.39 at 5 mo to 1.05 at 8 
mo, 1.14 at 12 mo, and 0.76 at 15 mo. 
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Table 4. Total estrogens, triiodothyronine and thyroxine concentrations 
in cattle at different ages 
Hormone Age 
5 mo 8 mo 12 mo 15 mo SE 
Total estrogens, 
pg/ml® 11.1 7.3 5.9 10.6 0.7 
Tri iodoAyronine, 
ng/ml° 1.4 2.1 2.1 1.3 0.1 
Thyroxine, ug/dl° 7.0 10.5 11.3 10.1 0.5 
^Concentrations of total estrogens at 5 and 15 mo are greater than 
those at 8 and 12 mo (P<0.0005). 
^Triiodothyronine concentrations at 5 and 15 mo are less than those 
at 8 and 12 mo (P<0.0001). 
^Thyroxine concentration at 5 mo is less than the following ages 
(P<0.001). 
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Table 5. Insulin and glucose concentrations before and after feeding in 
cattle at different ages® » 
Period Age 
5 mo 8 mo 12 mo 15 mo SE 
Prefeeding 
Insulin, ng/tnl^ 0.32 0.76 0.80 1.28 0.05 
Glucose, mg/dl° 82.4 93.3 90.8 85.8 1.7 
0-4 hr Postfeeding 
Insulin, ng/ml*^ 0.20 0.82 0.77 1.04 0.05 
Glucose mg/dl® 73.7 86.9 87.6 80.1 1.4 
4^8 hr Postfeeding 
Insulin, ng/ml^ 0.19 1.06 0.79 0.99 0.05 
Glucose, mg/dl9 74.0 90.8 90.9 83.5 1.7 
^Intact and castrated male and fanale values were not different. 
^Insulin at 5 mo is less than any other age (P<0.0001), While at 15 
mo is greater than any other age (P<0.0001). 
Ssiucose at 8 and 12 mo differs from 5 mo (P<0.001) and 15 mo 
(P<0.04). 
^Insulin at 5 mo is less than any other age (P<0.001), while at 15 
mo is greater than any other age (P<0.02). 
^Glucose at 8 and 12 mo is similar, but all other values differ 
from each other (P<0.0002). 
^Insulin at 8 and 15 is the same, however, all other values differ 
from each other (P<0.009). 
^Glucose at 8 and 12 mo is similar, but all other values differ 
from each other (P<0.004). 
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DISCUSSION 
The data presented here are part of an extensive study of growing 
intact and castrated male and female cattle in which GH secretion 
patterns, Œ secretion rates, Œ metabolic clearance rates, GH 
half-life, GH response to GH^releasing factor, Sm^c, growth"related 
hormones, and changes in body composition were examined as the cattle 
aged. 
Intact males had higher levels of sex steroids than steers, heifers 
or ovariectomized heifers. Bulls had the only measurable concentrations 
of testosterone. Which increased from 5 mo to 12 mo and then leveled 
off. Others have observed an elevation in testosterone beginning at 6 
to 8 mo (14). In that study, a rise in testosterone coincided with 
spermatogenesis which commenced around 5 mo (14). In our study, bulls 
also had elevated concentrations of total estrogens, vAiich may have been 
due to the aromatization of testosterone (15). Both testosterone and 
estrogens have been shown to increase GH secretion (16^21). In the 
previous paper (9), it was shown that as these bulls aged they 
maintained a greater baseline GH concentration in the plasma with more 
secretion periods of greater amplitude than steers, heifers or 
ovariectomized heifers. The high frequency and amplitude of GH 
secretory periods and spikes at 12 and 15 mo of age observed only in 
bulls may have been due to higher testosterone concentrations in the 
plasma or due to the combined effects of testosterone and estrogen. 
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Many of the effects of GH on growth have been considered to be 
mediated through Sm-C (16, 22^24). In the present study, we observed 
that bulls had higher concentrations of Sm-C, which increased 
dramatically from 5 to 8 mo and continued to increase up to 12 mo of 
age. Sm^-C concentrations increased in all animals up to 12 mo while 
plasma concentrations of GH declined. In humans, Sm*^ also increased 
with age while GH declined (16, 24). In bulls, the episodic pattern of 
GH secretion that was sustained during aging may have been responsible 
for the elevated Sm-C concentrations. Several authors have suggested 
that the greater Sm-C levels were more related to sexual maturity than 
to the aging process (24-25). The changes in Sm-C concentrations in 
the plasma of bulls were similar to changes in testosterone. In human, 
Sm^C levels have been observed to increase rapidly in prepubertal boys 
that were able to secrete GH (26^27). In ruminants, elevated 
concentrations of SAi'^C have been associated with faster growing breeds 
of cattle and sheep (23) and adequate nutrition (28). 
The sex steroids have also been associated with alterations in 
thyroid hormone status of animals (15, 20-^21). Thyroxine levels were 
higher in females than male cattle and triiodothyronine concentrations 
were elevated in ovariectomized heifers. It has been reported that 
testosterone and estrogens decreased concentrations of free thyroid 
hormones in the plasma which, in turn, decreased the energy requirement 
because of decreased protein turnover (21). Elevation of 
triiodothyronine in ovariectomized heifers may have been caused by low 
concentrations of sex steroids in plasma. 
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Insulin and plasma glucose concentrations in plasma were not 
altered castration, or between sexes. Similar insulin concentrations 
have been observed between steers and heifers, as well as between bulls 
and steers (29). Although insulin has been associated with increased 
amino acid uptake, protein synthesis and Sm-C secretion, and decreased 
proteolysis to enhance growth (16, 29^30), the authors of this study did 
not observe differences in insulin between the sexes in the study to 
account for differences in growth. 
Insulin levels increased with age in the cattle, while plasma 
glucose concentrations were elevated at 8 and 12 mo of age. The insulin 
increase with age in the present study was similar to other studies in 
ruminants in which insulin increased with increasing body weight (7^8, 
16, 31-32). The glucose:insulin ratio decreased as the animals aged in 
this study, indicating that more insulin was required to metabolize the 
same quantity of glucose. It has been suggested that increased insulin 
during aging may be the result of decreased metabolic clearance rate, 
decreased extracellular fluid volume, decreased insulin receptor 
binding, or reduced potency of insulin degradation in cells as body 
weight increases (31). 
Plasma concentrations of insulin were not altered by feeding in 
this experiment. The animals normally had free access to their feed. 
Ruminants that had free access to feed had fewer changes in plasma 
insulin and glucose levels as well as decreased GH oscillations (33-34). 
In contrast, when ruminants are meal fed once or twice daily, insulin 
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increased 2 hr after feeding and peaked within 4 hr and glucose 
increased 4 to 6 hr after feeding (31, 35-38). 
Several hormone concentrations may have been confounded by age and 
season. The warm months of summer and fall occurred when the cattle 
were 5 and 15 mo of age, whereas cattle 8 and 12 mo in age were tested 
in winter and spring. At 8 and 12 mo, total estrogen levels were low, 
while triiodothyronine and glucose were high in the cattle. Anderson et 
al. (39) also observed increased triiodothyronine in growing cattle in 
winter than in summer. However, Verde and Trenkle (8) did not observe 
seasonal cycles of thyroid hormones in cattle. 
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SECTION VI. EFFECT OF AGE, SEX AND CASTRATION 
ON BODY COMPOSITICM DURING AGING: 
INFLUENCE OF ENDOCRINE CHANGES ON 
BODY COMPOSITION 
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ABSTRACT 
The influence of age, sex, and castration on body composition in 
beef cattle was studied in bulls, steers, heifers, and ovariectomized 
heifers at 8, 12 and 15 mo of age. Body composition was determined by 
use of dilution of deuterium oxide. Between 8 and 12 mo of age, the 
rate of daily protein and fat deposition (kg/d) was: heifers, 0.12, 
0.52; steers, 0.16, 0.42; ovariectomized heifers, 0.15, 0.40; and bulls, 
0.21, 0.31. Bulls had different amounts of both protein and fat gain 
than the other animals. Differences in percent body protein, water, 
fat, and ash between 8 and 12 mo were associated with a decrease in 
growth hormone (GH) secretion rate/kg body weight (SR/kg bwt). Between 
12 and 15 mo of age, the rate of daily protein and fat deposition was: 
ovariectomized heifers, 0.05, 0.65 kg; steers, 0.13, 0.54 kg; bulls, 
0.15, 0.50 kg; and heifers, 0.08, 0.46 kg. Daily protein deposition was 
higher in bulls and steers than intact or ovariectomized heifers. An 
increase in plasma insulin was associated with an increased rate of fat 
gain between 12 and 15 mo of age. Overall GH concentrations over time 
were negatively related to percent ençty body fat and positively related 
to percent empty body protein as the cattle aged. GH SR/kg bwt was 
positively related to percent body protein and negatively related to 
percent empty body fat during aging, and kidney, heart and pelvic fat, 
subcutaneous fat over the ribs and yield grade of the carcasses at 15 
mo. The GH:insulin ratio was positively associated with percent empty 
body protein and negatively associated with percent empty body fat and 
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carcass kidney, heart and pelvic fat. Œ and insulin had the strongest 
relationships with rates of protein and fat deposition. 
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INTRODUCTION 
Growth of animals is characterized by an increase in tissue and 
organ mass. Because bone, muscle and fat grow at different rates (1), 
body composition varies according to the stage of development. 
Utilization of nutrients for synthesis of body tissues can be altered by 
factors such as nutrient intake, breed, sex, and age. Because the 
administration of growth hormone (GH) to domestic animals increased lean 
carcass mass (2-3), some studies have examined the association between 
endogenous GH concentration and body composition (4^6). In cattle, GH 
secretion rate (SR) has been positively correlated with growth of lean 
tissue, while negatively correlated with carcass adipose (4). However, 
this study was only conducted with steers and a study with male and 
female cattle was inconclusive (5). Differences in GH concentrations 
existed between intact and castrate male ruminants (7) as well as 
between males and females (8). Also, the body composition of bulls, 
steers, heifers, and ovariectonized heifers was shown to be different at 
slaughter (9). Therefore, the relationship between body composition and 
Oi needs to be compared in intact and castrated male and female cattle. 
In some cases, positive relationships between insulin concentrations and 
adipose deposition have been observed in cattle (4-5), whereas other 
studies have failed to substantiate this (10). Somatomedin^ (Sm-C), 
thyroid hormones and sex steroids are required for stimulation of muscle 
growth but their relationships with body composition in cattle have not 
been established. 
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In order to resolve some of the endocrine correlations with body 
protein and fat deposition during growth, bulls, steers, heifers, and 
ovariectoroized heifers at three stages of development served as models 
to study body composition changes as well as the relationships existing 
between empty body composition and measurements of growth-related 
hormones. 
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MATERIALS AND METHODS 
The animals and diet used in this study have been described 
elsewhere (11). Individual feed intake was recorded daily and animals 
were weighed every 14 days front 10 to 15 mo of age. Bulls, heifers, 
steers, and ovariectomized heifers, four of each, were injected via an 
indwelling jugular cathetei with 0.15 g deuterium oxide (D20)Ag bwt 
followed by 5 ml of sterile saline. Injections were givai at 8, 12 and 
15 mo of age. A 2^ml blood sample was withdrawn to clear the catheters 
before taking 10»rol samples at 4, 7, 10, 14, 24, 30, 36, 48, 72, and 120 
hr after DgO injection. Blood samples were placed in dry, screw-top 
culture tubes containing 20 U of heparin and stored at 4*0 for analysis. 
Water from the samples was isolated by vacuum sublimation and assayed 
for DgO by infrared spectrophotometry as described by Arnold et al. 
(12). A single-'compartment model (13) was used to estimate empty body 
composition of cattle from concentrations of DgO in blood water. 
Animals were slaughtered at 15 mo of age in a commercial abattoir 3 
weeks after the last DgO injection. Quality grades and percent kidney, 
heart and pelvic (KHP) fat of each carcass were determined by an 
official of the United States Department of Agriculture. All 
measurements except carcass weight were taken after chilling for 24 hr. 
Yield grade was calculated using an equation described by Rust (14): 
yield grade=2.5 + 2.5(Ribfat, inches) + 0.2(%KHP fat) + 0.0038 (hot 
carcass weight, pounds) - 0.32(Ribeye area, inches). 
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Data were analyzed using a split-plot model (15) of the general 
linear models procedures of SAS (16). Linear regressions were 
calculated over time to determine the relationship between hormone 
concentrations and body composition in the cattle. The corresponding 
hormone concentrations and percent empty body faty protein, water, and 
ash at each age for all groups of cattle were regressed. 
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RESULTS 
Both sex and castration influenced daily gain and feed intake 
(Table 1). Between 10 and 12 mo of age, heifers gained less than bulls, 
steers or ovariectomized heifers (P<0.04) despite the fact that feed 
intake for heifers was similar to bulls and greater than steers 
(P<0.03). Heifers had the greatest feed requirement per kg of gain 
(P<0.0003). Between 12 and 15 mo of age, heifers and ovariectomized 
heifers gained less than steers (P<0.04) and bulls (P<0.01). Heifers 
(P<0.008) and ovariectomized heifers (P<0.02) consumed less than bulls 
during this period. The feedigain ratio was not altered by sex or 
castration over the 12 to 15 mo period. 
Changes in empty body composition between 8 and 12 mo were affected 
by sex and castration (Table 2). At 8 mo and a body weight of 239 kg, 
bulls were composed of 21.7% fat, 17.4% protein and 3.9% ash on an empty 
body basis. Steers and ovariectomized heifers were not different from 
bulls at 8 mo, being 22.3% and 23.7% fat, 17.3% and 17.1% protein, and 
3.9% and 3.8% ash at body weights of 200 and 203 kg, respectively. At 8 
mo, heifers (247 kg) differed from steers (P<0.009) and bulls (P<0.003) 
in percent fat (26.0%), protein (16.7%) and ash (3.8%). Bulls had a 
greater rate of gain between 8 and 12 mo than heifers (P<0.03) and 
ovariectomized heifers (P<0.05). Fat gain was the greatest for heifers 
(52% empty body weight gain) followed by steers and ovariectomized 
heifers (38% empty body weight gain), and then bulls (25% empty body 
weight gain). The high fat gain in heifers was offset by lower gains of 
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water/ protein and ash. Water gain was the greatest in bulls (P<0.02), 
and steers gained more water than heifers (P<0.03). Protein and ash 
gain were highest in bulls (P<0.03). Steers had greater daily gains of 
protein and ash than heifers (P<0.05). 
Sex and castration influenced the gain of water, protein, fat, and 
ash between 12 and 15 mo (Table 3). Bulls and steers had higher average 
daily gains than heifers (P<0.01 and P<0.03, respectively) and 
ovariectomized heifers (P<0.02 and P<0.04, respectively). Daily water 
gain was the lowest in ovariectomized heifers and was lower than bulls 
(P<0.0008) and steers (P<0.004). Heifers also had less water gain than 
bulls (P<0.01). Daily gain of fat was not different between bulls, 
steers, heifers, or ovariectomized heifers, however, the percent of the 
daily gain deposited as fat was 44% in bulls, 50% in steers, 61% in 
heifers, and 83% in ovariectomized heifers. Protein gains were lower in 
females than bulls (P<0.006) or steers (P<0.03). Ash gains were also 
lower in females than bulls (P<0.0007) or steers (P<0.004). 
Carcass measurements were affected by sex and castration (Table 4). 
Live weight of ovariectomized heifers was less than males (P<0.02). Hot 
carcass weight was less for ovariectomized heifers than bulls (P<0.004) 
and heifers (P<0.04). Bulls had larger ribeye areas than steers and 
ovariectomized heifers (P<0.03). Bulls had less ribfat (P<0.02) and KHP 
fat (P<0,01) than steers, heifers or ovariectomized heifers. Heifers 
had the greatest amount of subcutaneous fat over the ribs (P<0.04). 
They also had greater amounts of KHP fat than steers (P<0.01). Bulls 
had lower quality (P<0.005) and yield grades (P<0.02) than steers. 
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heifers or ovariectomized heifers. Dressing percentage was not 
different between sexes or between intact and castrated animals. 
Table 1. Daily feed intake, body weight gain and feedigain ratio in 
intact and castrated, male and female, cattle 
Period Bulls Steers Heifers 
Ovariec-» 
tomized 
Heifers SE 
10*12 mo 
Average gain. kg/d® 1.49 1.48 1.10 1.35 0.09 
Feed intake, 
kg/day" 9.3 8.1 9.6 8.7 0.4 
Feed/gain® 6.3 5.5 8.3 6.4 0.3 
12*15 mo 
Average gain. kg/d^ 1.17 1.10 0.76 0.81 0.1 
Feed intake, 
kg/day® , 11.4 10.0 9.0 9.6 0.6 
Feed/gain 9.8 9.6 11.7 12.4 0.5 
^Heifers gained less than any other group (P<0.04). 
^Steers ate less than heifers (P<0.03) and bulls (P<0.05). 
^Heifers had the highest feedcgain of all animals (P<0.0003). 
^Heifers and ovariectomized heifers had less gain than steers 
(P<0.04) and bulls (P<0.01). 
®Bulls ate more than heifers (P<0.008) and ovariectomized heifers 
(P<0.02). 
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Table 2. Changes in en^ty body gain between 8 and 12 mo in intact and 
castrated, male and female, cattle 
Ovariec-i 
tomized 
Item Bulls Steers Heifers Heifers SE 
Average daily gain, kg® 1. :24 1. ,11 1. ,00 1. ,04 0. 07 
Total weight gain, kg® 164 147 133 137 8 
Water gain, kg/day^»® 0. 68 0. ,50 0. 34 0. ,46 0. ,05 
Fat gain, kg/day^'d 0. 31 0. 42 0. 52 0. ,40 0. ,03 
Protein gain, kg/day^'® 0. 21 0. 16 0. 12 0. 15 0. ,01 
Ash gain, kg/day^'® 0. 047 0. 036 0. 027 0. 034 0. 003 
^Bulls differ from heifers (P<0.03) and ovariectomized heifers 
(P<0.05). 
^Bmpty body basis. 
°Bulls differ from all other animals (P<0.02). Steers differ from 
heifers (P<0.03). 
^Bulls differ from steers (P<0.04) and heifers (P<0.0009). Heifers 
differ from ovariectomized heifers (P<0.03). 
®Bulls differ from all other animals (P<0,03). Steers differ from 
heifers (P<0.05), 
173 
Table 3. Changes in empty body gain between 12 and 15 mo in intact and 
castrated, male and female, cattle 
Ovariec^ 
tomized 
Item Bulls Steers Heifers Heifers SE 
Total weight gain, kg® 89 84 59 6 7 
Water gain, kg/day^'C 0. ,46 0. 38 0. 20 0. 07 0. 06 
Pat gain, kg/day^ 0. ,50 0. 54 0. 46 0. 65 0. 09 
Protein gain, kg/day^ 0. 15 0. ,13 0. 08 0. ,05 0. ,02 
Ash gain, kg/dayb'd 0. 034 0. 030 0. ,017 0. ,012 0. 004 
^Ovariectomyzed heifers differ from bulls (P<0.02) and steers 
(P<0.04). Heifers differ from bulls (P<0.01) and steers (P<0.03). 
^Bnpty body basis. 
^Ovariectcxnized heifers differ from bulls (P<0.0008) and steers 
(P<0.004). Heifers differ from bulls (P<0.01). 
'^Ovariectomized heifers differ from bulls (P<0.0007) and steers 
(P<0.004). Heifers differ from bulls (P<0.006) and steers (P<0.03). 
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Table 4. Carcass measurements in intact and castrated, male and female, 
cattle at slaughter 
Iten Bulls Steers Heifers 
Ovariecd 
tomized 
Heifers SE 
Liveweight, kg® 504 469 458 423 15 
Carcass weight, kg^ 299 272 282 247 10 
Ribeye area, omf/c 81 72 75 72 2 
Ribfat, an4 0.7 1.2 1.7 1.2 0.1 
Kidney, heart and 
pelvic fat, %® 1.4 2.5 3.6 3.3 0.3 
Quality gradef'9 4.3 8.0 7.3 7.8 0.6 
Yield gradeh 1.9 2.9 3.5 2.9 0.6 
Dressing % 59 58 62 58 1.2 
^Ovariectomized heifers weigh less than males (P<0,02). 
^Ovariectomized heifers weigh less than bulls (P<0.004) and heifers 
(P<0.04). 
°Bulls have a larger ribeye area than steers and ovariectomized 
heifers (P<0,03). 
^Bulls have less ribfat than all other animals (P<0,02), while 
heifers have more ribfat than any others (P<0.04), 
®Bulls have less kidney, heart and pelvic fat than other groups 
(P<0.01), while heifers have more than steers (P<0.01). 
^Choice+=9, choice=8, choice-=7, good+=6, good=5, and good-=4. 
^Bulls have a lower quality grade than any other group (P<0.005). 
^Bulls have a lower yield grade than any other group (P<0.02). 
175 
DISCUSSION 
In this study, the rate of protein and fat deposition differed 
between bulls, steers, heifers, and ovariectomized heifers as they 
matured. These data corresponded with other studies, vAiich showed that 
females fattened at lighter body weight than castrate or intact males 
(9, 17). This was most likely the result of higher testosterone in 
bulls, which has been reported to accelerate muscle growth by 
hypertrophy and possibly potentiating the effects of GH on muscular 
growth (18). 
Between 8 and 12 mo, a significant decrease in GH SR occurred, 
whereas, between 12 and 15 mo, the concentration of plasma insulin 
significantly increased in all the animals. Meanwhile, composition of 
the gain changed from less protein and water to more fat from the 8 to 
12 mo period to the 12 to 15 mo period. These endocrine changes as 
related to specific periods of aging and body composition changes have 
not previously been reported. The decline in GH SR between 8 and 12 mo 
of age may have been a signal to shift the type of tissue deposition 
from protein to fat, and the increase in insulin between 12 and 15 mo of 
age may have enhanced the rate of adipose deposition. 
During the 8 to 15 mo period, several relationships were observed 
between the endocrine system and body composition in cattle. Overall GH 
concentrations and GH SR/kg body weight were negatively related to body 
fat (r=-0.82 and ^0.90, respectively). GH SR/kg body weight at 15 mo 
also was negatively related to KHP fat, subcutaneous fat over the ribs 
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and yield grades (r=-0.96, -0.99 and -0.98, respectively). These 
results were similar to earlier studies in which negative relationships 
between GH and GHI Sl^kg body weight with carcass adipose and fat 
thickness over the ribs were observed (4^5). Percent body protein was 
positively related to overall Qi concentrations, GH metabolic clearance 
rate/kg body weight and GH SR/kg body weight (r=+0.82, +0,53 and +0,90, 
respectively), again similar to previous results (4). The relationships 
between GH and protein and fat deposition were in agreement with the 
accepted role of GH in stimulating protein synthesis and decreasing the 
quantity of adipose tissue. 
An association between insulin and percent body protein (r=-0.41) 
and fat (r=+0.42) was observed in this study. It is known that insulin 
increases the cell size of skeletal muscle cells and Œ is important for 
increasing the number of nuclei in muscle cells, both hormones enhancing 
amino acid uptake into the cells (19-20). The effect of GH:insulin 
ratio on growth has not been established, but a high ratio is usually 
associated with muscle deposition and a low ratio with fat deposition 
(21-122). Large breeds of cattle have more GH and less insulin, which is 
associated with prolonged growth of skeletal muscle and a delay in 
adipose tissue deposition (21). In the present study, the GH:insulin 
ratio was positively related to body protein (+0.82) and negatively 
related to percent body fat (-0.83) and KHP fat in the carcass (-0.99). 
Increased adipose deposition, which coincided with increased plasma 
insulin and decreased GH per unit of body tissue, was associated with 
increasing age, time and body weight. 
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Sm-C, reported to be positively associated with growth (23), had 
low correlations with changes in body composition between 8 and 15 mo of 
age in the present study. It was negatively related to percent body fat 
(r=^0.31) and positively related to protein (r=+0.31). It has been 
shown that GH actions on adipose were not mediated by Sm-C (24). 
Therefore, the low correlations between changes in body composition and 
plasma concentrations of Sm-'C may have been due to adipose being the 
most rapidly growing tissue during the 8 to 15 mo period. 
The different rates of fat and protein deposition between 8 to 12, 
and 12 to 15 mo of age may have influenced reductions in GH secretion. 
It is possible that the tissue being deposited at the highest rate may 
have had some feedback on endocrine glands. Several researchers have 
noted that GH release by GH-releasing factor was impaired during periods 
of obesity in humans (25-28). In rats, an elevation of free fatty acids 
stimulates somatostatin secretion which in turn suppressed secretion of 
GH by GH-releasing factor (28). 
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GENERAL DISCUSSION 
Administration of growth hormone-releasing factor (GHRF) induced 
growth hormone (GH) secretion in ruminants (Sections I<>IV). The animals 
responded to both single and multiple injections of GHRF with a release 
of GHr however, animals with an intact hypothalamic stalk did not always 
respond (Section II). In the hypothalamic stalk-transected (HST) 
calves, GHRF always induced Œ secretion (Section III). Continuous 
infusion of somatostatin (SRIH) severely inhibited the GH response to 
GHRF after HST. Both SRIH and GHRF induced GH responses similar to 
those observed in the animals before surgery. Therefore, it was 
concluded that the pituitary was still capable of responding to stimuli. 
The major difference in response to SRIH infusion between the intact and 
HST calves, was the lack of somatotrophic rebound after SRIH infusion 
was discontinued in the HST calves. The differences in GH secretion in 
response to GHRF before and after HST may be that in HST animals, 
endogenous GHRF and SRIH were not acting on the pituitary prior to 
treatment with exogenous GHRF or SRIH. In the absence of endogenous 
GHRF, the HST pituitary did not have stored GH. Thus, after SRIH 
infusion, a sonnatotrophic rebound was not observed. Similarly, 
endogenous SRIH did not prevent the HST pituitary from releasing GH 
after an injection of GHRF. Without SRIH acting on the pituitary in HST 
animals, GH was released after every injection of GHRF. Therefore, 
intact animals are more likely to have variable responses to exogenous 
GHRF unless endogenous SRIH release is suppressed. 
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When CHRP was injected every 4 hr for 24 hr in sheep (Section I) or 
in cattle at 3-hr intervals for 42 hr (Section II), the amplitude of the 
GH response varied. The GH response to GHRF decreased after feeding and 
slowly increased with each injection of GHRF until the next feeding. 
This difference in amplitude of GH release induced by a similar dose of 
GHRF may be related to gut SRIH release. Exogenous SRIH suppressed the 
GH response to GHRF in calves (Sections II-III). In an additional 
study, the GH response to GHRF in sheep that were fed or had the cranial 
sac of the rumen artificially distended with a water-filled balloon to 
simulate gut fill caused by feeding, was suppressed compared to animals 
that were fasting (1). Based on these findings, it was concluded that 
SRIH or neural transmission from tension receptors in the cranial sac of 
the rumen transmitted via the vagus nerve (2) inhibited the ability of 
GHRF to release GH. 
Higher concentrations of GH and GH secretion rates (SR) were 
associated with higher amounts of protein and less adipose deposition 
(Sections IV and VI). The GH profiles, rates of secretion and response 
to GHRF declined with increasing age. Intact males had higher GH SR and 
GH baseline with more periods of episodic secretion than the castrate 
males or females, or intact females. Bulls did not lose their episodic 
secretion of GH as they aged, whereas the other groups did. The decline 
in GH SR, GH profiles and GH response to GHRF as the animals aged may be 
related to the differences in nitrogen retention observed between older 
sheep and prepubertal calves when they were administered similar doses 
of GHRF at 4-hr intervals (Sections I-II). After 5 days of GHRF 
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treatment, the older sheep had a significant reduction of urinary 
nitrogen, indicating an increased postabsorptive metabolic effect on 
nitrogen. After 5 or 10 days of GHRF treatment, prepubertal bull calves 
did not have significant improvements in any of the nitrogen measure­
ments. Because the older sheep had a low baseline of GH, probably with 
few periods of secretion, these animals may not have needed much GH 
stimulation to induce a positive metabolic change in their nitrogen 
utilization. The calves had higher GH baseline, probably with many 
periods of GH secretion of high amplitude. The additional GHRF 
administered to calves seemingly was not adequate to induce significant 
inçrovements in nitrogen measurements. 
Because the endocrine and nitrogen measurements in the calves 
indicated a general improvement in nitrogen efficiency, GHRF treatment 
may be effective in stimulating nitrogen retention in young animals. 
When GHRF was administered as a continuous infusion to steers, the 
amplitude of endogenous GH pulses was increased (3), while in bull 
calves, episodic secretion of GH was stimulated (4). Moseley et al. (5) 
demonstrated that continuous infusion of GHRF increased nitrogen 
retention in young bull calves. Based on the evidence presented, young 
animals may need either greater quantities of GHRF administered as a 
pulse injection or require continuous administration of GHRF to cause a 
significant increase in nitrogen retention. 
An additional possibility for stimulating GH secretion may be the 
simultaneous administration of testosterone and GHRF. Whereas 
endogenous testosterone helped to sustain GH secretory profiles during 
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aging in bulls, the simultaneous administration of low concentrations of 
testosterone with CHRP may potentiate or prolong the GH response in 
ruminants. 
Even though GH concentrations may be increased with GHRF 
administration, the resulting growth responses may be limited by 
inadequate nutrition as well as an imbalance of endogenous concentra­
tions of thyroid hormones, insulin or other growth factors. The optimum 
response to an anabolic agent may be dependent upon the overall balance 
of the endocrine system. Nevertheless, our results showed that with 
high levels of nutrition, GHRF could be used to enhance the utilization 
of absorbed nitrogen in older sheep. Although statistically significant 
increases in nitrogen retention with GHRF treatment were not observed in 
young calves, the trends toward increased somatomedin-C concentrations, 
GH concentrations, nitrogen retention, weight gains, and feed intake 
indicated the potential for significant enhancement of nitrogen 
retention with GHRF under different administration. 
185 
ADDITIONAL LITERATURE CITED 
1. Trenkle A, Plouzek C. Influence of feeding on growth hormone 
secretion and growth hormone-^releasing factor response in sheep. Proc 
67th Annual Meeting Endocrine Society, Baltimore, MD, pl94, 1985. 
[Abstr] 
2. Leek, BF. Reticulo^^ruminal mechanoreceptors in sheep. J Physiol 
(London) 202:585-609, 1969. 
3. Moseley WM, Krabill LF, Friedmann AR, Olsen RF. Administration of 
synthetic human pancreatic growth hormone-^releasing factor for five days 
sustains raised serum concentrations of growth hormone in steers. J 
Endocrinol 104:433^439, 1985. 
4. Enright WJ, Zinn SA, Chapin LT, Tucker HA. Growth hormone response 
of bull calves to growth hormone-releasing factor. Proc Soc Exp Biol 
Med 184:483-488, 1987. 
5. Moseley WM, Huisman J, VanWeerden EJ. Serum growth hormone and 
nitrogen metabolism responses in young bull calves infused with growth 
hormone-»releasing factor for 20 days. Domest Anim Endocrinol 4:51-59, 
1987. 
186 
ACKNOWLEDGMENTS 
Completing a dissertation requires the assistance of many 
individuals. I would like to thank my committee members: Allen 
Trenkle, Marit Nilsen-Hamilton, A. Dare McGilliard, Lloyd L. Anderson, 
Donald Hotchkiss, and Steven Nissen; for serving on my committee and for 
their assistance. I would like to express special thanks to Lloyd 
Anderson for providing the o^)ortunity to work with him on the first 
growth hormone-releasing factor experiments in cattle and Marit 
Nilsen-Hamilton for her special teaching and assistance. 
I must give special thanks to Navella Kenagy. Her in-depth 
knowledge about the University solved many of iry problems and she always 
had the correct form or procedure at hand. 
The others that made my dissertation a reality include: Joan 
Rettig, fellow graduate students, Rod Berryman, Carl Johnson, John 
Lawrence, Mahlon Sheldon, Craig Bohnker, and the ruminant nutrition farm 
crew. Worm should be thanked for her companionship during my research 
and for maintaining my sanity during the writing of this manuscript. 
typist, Barbara Marvick, deserves appreciation for her dedication and 
patience in typing this dissertation. My admiration and gratitude go to 
Mrs. Bishop in the Thesis Office for her help in the preparation of this 
dissertation. 
My parents deserve a special acknowledgment. Their unending 
support, encouragement, assistance, and devotion throughout iry studies, 
always gave me the extra boost to survive. 
187 
Finallyr I would like to thank ny husband, David Morris. His love 
and understanding sustained me during the bleakest times as well as his 
support vAien the "normal" lines of support provided in a graduate 
program expired. 
188 
APPENDIX. STATISTICAL PROCEDURES FOR GROWTH 
HORMONE PROFILE ANALYSIS 
The statistical method for detection of hormone secretory spikes 
consisted of partitioning the growth hormone (GH) concentrations from 
sequential plasma samples for each experimental unit (animal) into two 
subgroups by the skewness coefficient test. The first subgroup, 
inliers, was those observations v^ich constituted the normal, random 
variation expected among samples. It was assumed that inliers did not 
deviate significantly from a normal distribution. This subgroup was 
considered as the baseline population and was used to determine mean 
baseline GH concentrations. The second subgroup, outliers, contained GH 
concentrations which were abnormally high but occurred in a random 
manner. Outliers were obtained by dropping points from the right side 
of the frequency distribution until the normal distribution of inliers 
was obtained. Thus, outliers constituted the skewness and, therefore, 
constituted the secretory spikes. It was assumed that both subgroups 
did not deviate from a normal distribution, but if the outlier 
population, in particular, were found to conform to some other 
distribution, nonparametric tests rather than the parametic tests were 
used. 
After entering the GH concentrations and corresponding time data 
for each experimental unit, the existence of linear, quadratic or no 
trends were determined by calculating Spearman correlation coefficients. 
Linear trends indicated that the samples varied about a straight line. 
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quadratic trends indicated a curved baseline and no trends had no 
patterns. The baseline was adjusted for linear and quadratic trends 
before time secies analysis to exclude long^^term changes in the baseline 
from affecting the frequency and amplitude of secretory spikes. Because 
secretory periods of equal amplitude raised observed levels to different 
maximum values when the baseline changes, removing trends was essential 
for peak identification. If Spearman correlation coefficients were 
significant, the observations were regressed on time and the adjusted 
regressed values used in a time series analysis. If Spearman 
correlation coefficients were not significant, the data were entered 
directly into the time series analysis. The time series analysis was 
used to ranove positive serial correlation normally observed between 
adjacent observations of sequentially collected data. Since an 
assumption of independence of observations was required in the 
statistical tests, such as skewness coefficient test, a moving average 
from the time series analysis of the first order was fit to remove bias. 
The time series analysis was performed to adjust either the 
original data or the adjusted regressed values for positive serial 
correlation. The data as adjusted by time series and autocorrelations 
were calculated with a lag of one on the residuals to determine spike 
locations. The resulting 15 maximum points of the time series residuals 
were tested as outliers using the skewness coefficient test within the 
univariate procedure of SAS (1). This procedure eliminates in each 
succeeding case the maximum value, so that the total number of 
observations reduces by one each time the next maximum value was 
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eliminated. If the skewness value calculated was larger than the table 
skewnesss value at a significiance of 5%, it was considered a GH spike 
or part of a spike. If the calculated skewness value was equal or less 
than the table value, the value was considered part of the baseline and 
regressions stopped. The GH baseline value was calculated by averaging 
the remaining GH values after the outliers or spikes were eliminated. 
Frequency of GH spikes was the number of separate spikes located over 
the time period. Amplitude of GH spikes was obtained from the 
corresponding GH concentration for those skewness values. Averaging the 
hormone values for each spike gave the spike amplitude. If the GH 
concentration returned to baseline or below for one or more samples, the 
spikes surrounded by the baseline samples were considered to be a period 
of secretion. The amplitude of the period of secretion was the mean of 
all GH samples with a residual greater than the skewness table value 
within the period. The overall mean was the average of all Œ samples 
for each experimental unit. 
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